rfhg_51189.1

Basic information about the TSS

---

TSS ID: rfhg_51189.1 Species: human Chr: chr3		Start: 146544851 End: 146544873 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3497137,EH38E2245914)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000472349.1:0 GeneID: 5359 HGNC/MGI_ID: HGNC:9092 UniProt_ID: C9JE06 Nearer transcript ids and distances: MP067537:10 ENST00000487389.5:114 ENST00000469266.1:124 LP895473:142 AB006746:142 AF098642:143 ENST00000486631.5:210 ENST00000448787.6:231 AK300181:231 ENST00000342435.9:244 NM_021105.3:244 AK313377:244 NM_001363874.1:256 BC017901:267 BC032718:272 ENST00000494568.5:273 ENST00000462666.5:281 ENST00000463777.5:296 ENST00000468985.5:296 NM_001363872.1:296 ENST00000477974.1:298 ENST00000489775.5:304 BC021100:310 ENST00000478267.5:313 ENST00000488253.5:321 ENST00000493432.5:330 BC070251:330 view more...

Gene_name: phospholipid scramblase 1 Gene_symbol: PLSCR1 Gene_synonyms: MMTRA1B Gene_source: HGNC:9092

TATA-Box annotation

---

Distance to TSS:	-255
Nearest PromoterID:	NM_021105
Entrez ID:	5359
Nearest Unigene:	Hs.130759
Nearest Refseq:	NM_021105
Nearest Ensembl:	ENSG00000188313
Gene Name:	phospholipid scramblase 1
Gene Alias:	MMTRA1B
Gene Type:	protein-coding
CpG%:	0.045455
GC%:	0.521739
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PLSCR1 p2@PLSCR1 p3@PLSCR1 p4@PLSCR1 p5@PLSCR1 p6@PLSCR1 p7@PLSCR1 p8@PLSCR1 p9@PLSCR1
Sample		p1@PLSCR1	p2@PLSCR1	p3@PLSCR1	p4@PLSCR1	p5@PLSCR1	p6@PLSCR1	p7@PLSCR1	p8@PLSCR1	p9@PLSCR1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	8.57	1.56	12.27	2.14	0.39	0.00	0.19	0.58	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	9.31	4.65	12.14	1.62	0.20	0.20	0.00	1.21	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	7.52	3.28	9.65	1.16	0.96	0.00	0.19	0.39	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	5.82	1.87	10.81	1.46	0.00	0.00	0.21	0.21	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	6.75	2.70	9.45	1.12	0.90	0.00	0.22	0.00	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	7.56	2.52	12.21	1.55	0.78	0.19	0.00	0.58	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	45.32	11.33	12.42	3.49	1.74	0.22	0.22	0.44	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	31.73	13.81	8.96	2.18	3.15	0.73	0.24	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	43.38	10.26	7.05	2.14	2.56	1.07	0.43	0.21	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	67.82	19.13	8.69	1.74	11.01	1.16	0.58	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	58.61	19.81	7.28	0.40	4.85	0.81	0.81	0.00	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	60.98	16.67	8.13	0.81	4.07	0.81	0.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	6.45	1.29	5.64	0.48	0.48	0.00	0.00	0.32	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	7.52	1.65	7.82	0.45	0.15	0.00	0.30	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	6.37	1.32	7.46	1.10	0.22	0.00	0.00	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	5.78	2.26	6.79	0.75	0.25	0.00	0.25	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	5.24	1.09	6.99	0.66	0.22	0.00	0.00	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	7.59	2.11	3.37	0.00	0.00	0.42	0.42	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	6.93	3.73	10.66	1.07	1.07	0.00	0.53	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	6.17	1.05	7.07	1.96	0.00	0.00	0.15	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	6.68	1.60	8.15	1.20	0.53	0.00	0.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	6.73	1.55	5.87	1.21	0.00	0.00	0.17	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	5.56	1.55	7.24	0.52	0.00	0.00	0.13	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	6.55	0.97	6.55	0.24	0.24	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	5.16	1.29	5.93	0.77	0.77	0.00	0.26	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	4.75	1.58	6.96	0.95	0.32	0.00	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	3.30	1.10	7.14	1.65	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	4.48	1.18	5.66	0.47	0.24	0.00	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	4.36	1.94	5.01	0.81	0.32	0.00	0.00	0.48	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	4.89	1.63	7.24	0.72	0.18	0.18	0.00	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	5.86	1.05	3.98	0.63	0.21	0.00	0.00	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	6.06	1.37	5.67	1.56	0.39	0.20	0.39	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	6.33	0.63	6.12	1.06	0.21	0.00	0.21	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	8.41	2.97	7.26	0.99	1.15	0.00	0.16	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	5.80	0.56	5.05	1.31	0.56	0.00	0.75	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	7.47	1.34	4.60	0.77	0.00	0.00	0.19	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	8.99	3.68	2.86	0.41	0.82	0.00	0.00	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	9.67	3.02	6.25	1.21	0.20	0.00	0.00	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	8.37	2.43	5.94	1.35	0.54	0.00	0.27	0.27	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	14.16	2.16	4.80	1.92	0.96	0.00	0.24	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	8.94	2.82	4.94	0.94	0.47	0.24	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	14.49	5.12	5.71	1.17	0.88	0.29	0.15	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	17.29	4.64	4.01	2.11	0.63	0.63	0.63	0.21	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	15.21	5.07	4.90	1.75	0.70	0.17	0.52	0.35	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	16.26	4.82	4.82	2.21	0.80	0.40	0.20	0.80	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	18.61	6.98	6.75	2.09	0.70	0.00	0.00	0.47	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	18.95	5.04	6.72	1.44	0.72	0.00	0.00	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	22.06	8.35	4.17	0.60	1.79	0.00	0.00	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	24.89	5.98	5.27	2.39	1.20	0.00	1.44	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	23.66	6.87	4.04	2.43	0.81	0.20	0.20	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	26.23	8.20	4.10	1.84	2.05	0.00	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	33.36	8.67	7.34	2.22	3.56	0.22	1.11	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	125.93	55.97	27.98	13.99	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	26.61	5.68	5.68	1.42	2.48	0.00	0.71	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	29.16	6.63	2.65	1.33	1.99	0.66	0.99	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	37.75	15.94	8.39	5.87	0.84	0.00	0.00	1.68	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	35.36	13.78	11.48	2.30	2.30	0.46	0.00	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	40.51	8.10	5.83	1.94	1.62	0.00	0.00	0.32	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	32.76	4.50	3.85	1.28	0.96	0.00	0.00	0.96	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	24.20	11.32	8.17	2.83	2.51	0.00	0.63	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	33.14	7.05	9.17	2.12	3.53	0.00	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	28.04	5.05	5.61	1.68	0.56	0.00	0.56	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	24.68	18.31	3.98	0.80	3.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	27.18	11.55	6.80	1.36	2.38	0.00	0.68	0.34	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	32.49	7.80	3.90	0.97	1.30	0.00	0.32	0.00	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	20.59	5.68	4.97	1.42	1.06	0.35	0.00	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	64.66	16.16	64.66	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	173.74	39.49	15.79	7.90	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	24.38	1.95	5.36	1.46	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	15.87	3.47	2.48	0.50	0.99	0.00	0.00	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	14.54	1.88	7.04	0.94	1.41	0.00	0.00	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	19.54	1.66	4.31	1.99	0.00	0.00	0.33	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	21.96	1.24	2.78	0.62	0.00	0.31	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	24.46	3.36	3.06	0.61	0.92	0.00	0.31	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	22.17	8.55	22.65	3.48	1.27	0.48	5.23	0.16	0.48
Adipocyte - breast, donor2	11327-117E4	8.82	5.29	11.87	1.12	0.32	0.64	2.25	0.16	0.16
Adipocyte - omental, donor1	11473-119C6	6.11	1.91	13.74	0.89	0.76	0.13	0.76	0.25	0.25
Adipocyte - omental, donor2	11474-119C7	11.21	2.24	4.48	0.75	0.75	0.00	2.24	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	3.01	3.01	6.70	1.34	0.00	0.00	1.00	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	2.55	1.28	7.66	0.64	1.28	0.64	1.28	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	3.30	5.50	3.30	3.30	2.20	0.00	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	4.06	1.81	5.87	0.45	0.00	0.00	0.00	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	2.09	1.22	3.13	1.04	0.35	0.00	0.17	0.00	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	46.55	21.32	14.67	0.98	2.54	2.15	1.76	0.39	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	56.11	31.92	9.52	1.29	5.15	2.83	0.77	0.26	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	16.73	9.20	9.48	1.12	1.39	0.84	1.12	0.28	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	72.30	17.05	9.40	2.94	5.88	0.00	1.76	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	10.86	6.35	5.55	1.13	0.80	0.24	0.48	0.08	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	107.15	52.93	8.39	4.20	8.39	2.58	0.97	0.65	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	10.66	2.13	3.20	1.07	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	15.58	2.78	5.56	1.11	1.11	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	4.57	3.74	2.08	0.42	0.42	0.42	0.83	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	32.65	15.57	4.52	2.51	2.51	3.01	0.75	0.25	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	7.53	3.27	3.93	0.65	0.33	0.00	0.65	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	2.13	3.35	3.04	0.00	0.00	0.00	0.30	0.61	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	4.20	1.10	7.96	0.66	0.22	0.00	0.44	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	1.79	1.08	0.36	0.00	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	4.79	1.20	5.99	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	11.51	3.60	18.89	2.52	1.44	0.00	1.62	0.36	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	3.35	1.67	11.71	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	10.48	1.85	16.44	1.44	0.00	0.00	0.00	0.21	0.41
Anulus Pulposus Cell, donor1	11248-116E6	21.74	11.79	18.77	1.60	1.83	0.23	0.69	0.57	0.00
Anulus Pulposus Cell, donor2	11463-119B5	7.35	1.96	6.86	1.47	0.49	0.00	0.24	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	10.78	2.70	8.09	0.90	0.90	0.00	0.90	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	7.38	2.17	11.72	0.43	0.00	0.00	0.00	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	2.14	6.42	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	17.34	2.69	8.37	1.20	0.90	0.90	0.30	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	6.32	1.26	8.85	1.26	0.00	0.00	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	7.92	0.00	6.60	0.66	0.66	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	7.80	5.20	6.82	0.97	0.97	0.32	0.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	6.80	2.43	7.28	1.46	0.00	0.00	1.94	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	8.31	0.59	4.75	0.59	1.19	0.00	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	7.16	1.88	4.14	1.51	0.00	0.00	0.38	0.75	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	13.06	0.73	5.81	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	8.78	0.00	8.78	0.00	0.00	1.25	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	9.88	2.97	9.88	1.32	0.00	0.49	0.66	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	13.65	4.09	6.82	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	6.94	2.56	8.60	0.30	0.60	0.00	0.75	0.00	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	6.97	2.68	6.43	1.61	0.54	0.00	0.54	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	6.05	0.76	7.18	0.76	0.19	0.38	0.38	0.38	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	10.16	0.80	5.61	1.87	0.53	0.27	0.27	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	9.75	7.80	5.85	1.95	0.00	0.98	0.98	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	4.98	2.49	5.81	0.50	0.17	0.17	1.00	0.17	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	15.61	0.00	8.41	0.00	0.00	0.00	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	0.00	0.00	0.00	0.00	0.00	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	7.20	2.06	7.20	0.86	0.00	0.00	0.69	0.51	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	8.39	8.39	4.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	5.83	0.00	8.25	1.94	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	7.21	1.90	10.25	0.76	0.38	0.00	0.76	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	6.06	3.63	6.06	3.63	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	6.27	1.71	9.12	0.00	0.00	0.57	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	4.70	3.21	7.91	0.64	0.21	0.00	0.21	0.43	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	4.90	1.81	4.65	0.77	0.00	0.00	0.26	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	4.69	2.35	8.91	0.00	0.00	0.00	1.41	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	4.50	1.61	9.00	0.96	0.32	0.00	0.00	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	7.85	2.14	4.99	0.00	0.71	0.00	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	5.85	0.58	8.19	0.58	0.58	0.00	0.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	6.02	1.20	7.83	0.60	0.30	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	10.69	2.38	14.26	0.00	0.00	0.00	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	6.10	1.53	10.68	1.02	0.00	0.00	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	6.88	1.78	8.40	0.51	0.51	0.25	0.00	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	5.08	1.91	5.08	0.64	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	5.18	1.73	8.63	0.00	0.43	0.43	0.43	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	6.35	1.06	6.35	0.42	0.42	0.00	0.21	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	5.80	0.87	6.67	0.87	0.58	0.00	0.58	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	4.72	0.94	5.67	0.94	0.94	0.00	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	5.26	1.53	5.42	1.02	0.34	0.00	0.34	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	4.63	4.63	13.90	2.32	0.00	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	6.34	2.11	0.00	2.11	0.00	0.00	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	6.22	2.36	6.43	0.64	0.21	0.21	0.21	0.21	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	5.41	1.20	5.41	0.00	0.00	0.00	1.80	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	7.29	1.46	3.64	1.46	0.73	0.00	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	8.28	2.53	5.75	1.38	0.46	0.00	0.46	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	0.00	12.75	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	10.42	3.81	5.08	1.02	1.53	0.00	0.51	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	10.53	3.10	5.57	0.62	0.21	0.00	0.41	0.21	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	8.57	3.67	3.98	0.92	0.31	0.00	0.92	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	13.38	4.30	5.26	1.43	0.96	0.48	0.96	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	13.30	4.66	7.32	0.67	1.11	0.00	0.67	0.22	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	13.73	0.00	4.58	0.00	1.53	0.00	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	12.74	2.77	9.42	1.11	0.00	0.00	1.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	10.86	3.97	5.83	0.79	1.59	0.26	0.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	12.72	2.54	4.72	1.09	0.36	0.00	0.73	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	6.51	2.46	7.49	0.37	0.12	0.00	0.12	0.49	0.00
Astrocyte - cerebellum, donor2	11580-120F5	2.57	2.91	3.94	0.51	0.17	0.00	0.00	0.51	0.00
Astrocyte - cerebellum, donor3	11661-122F5	3.36	1.47	4.61	0.42	0.00	0.00	0.63	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	10.11	2.09	18.48	2.09	2.09	0.00	0.70	0.35	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	9.06	2.43	11.49	2.10	0.32	0.00	0.49	0.49	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	11.78	3.13	16.26	3.13	0.60	0.00	0.00	0.89	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	57.00	20.76	8.95	2.41	3.56	0.92	0.23	0.11	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	48.36	13.78	10.27	1.38	2.38	0.63	0.13	0.13	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	52.12	14.91	9.45	1.82	4.32	0.46	0.23	0.11	0.11
Basophils, donor1	12241-129G9	38.97	34.26	7.58	0.52	2.09	1.31	0.52	0.00	0.00
Basophils, donor2	12242-129H1	53.04	38.24	11.91	1.08	2.53	1.80	1.44	0.00	0.00
Basophils, donor3	12243-129H2	54.39	40.42	7.20	0.73	3.09	2.35	0.29	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	2.16	1.08	1.08	0.22	0.22	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	0.91	0.00	2.29	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	3.77	1.26	1.26	1.26	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	4.16	1.04	2.70	0.00	0.00	0.21	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	1.84	0.69	1.84	1.38	0.23	0.00	0.92	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	3.96	1.26	5.04	0.36	0.00	0.00	0.18	0.00	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	6.90	3.71	2.37	0.10	0.00	0.21	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	2.33	1.40	2.79	0.00	0.00	0.00	0.00	0.00	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	37.09	20.47	11.51	1.28	0.96	1.28	0.00	0.32	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	20.68	10.34	10.34	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	72.14	62.55	5.64	0.00	2.82	2.82	0.56	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	48.81	33.22	5.01	0.93	2.78	2.60	0.19	0.00	0.37
CD14+ Monocytes, donor3	11381-118B4	61.69	40.83	5.05	0.22	2.85	3.07	0.22	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	34.81	67.93	5.66	2.26	3.68	7.08	0.00	0.00	1.70
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	23.50	42.84	9.10	1.14	1.14	4.55	0.00	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	32.22	60.82	7.89	1.31	2.30	4.27	0.00	0.00	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	116.36	112.75	11.27	1.16	9.40	8.96	0.58	0.00	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	108.93	116.17	6.03	1.21	9.05	7.24	1.51	0.00	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	104.94	107.79	9.95	0.71	11.61	6.16	0.71	0.00	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	144.63	116.84	12.89	1.84	8.20	7.03	1.34	0.00	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	122.83	116.48	8.00	1.66	12.70	6.07	0.55	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	140.33	145.78	13.39	1.24	12.40	11.65	3.47	0.00	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	305.06	436.05	20.17	1.37	39.36	69.12	9.99	0.00	1.76
CD14+ monocytes - treated with BCG, donor2	11870-125B7	296.99	384.41	19.59	2.67	46.47	59.82	10.33	0.18	2.14
CD14+ monocytes - treated with BCG, donor3	11880-125C8	379.55	718.40	25.90	1.96	74.21	84.22	10.01	0.00	1.52
CD14+ monocytes - treated with Candida, donor1	11868-125B5	256.84	205.33	20.84	1.40	18.96	14.28	2.58	0.23	0.94
CD14+ monocytes - treated with Candida, donor2	11878-125C6	227.58	211.21	17.95	0.53	22.71	14.26	1.06	0.53	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	171.95	170.84	19.97	3.33	19.97	14.42	2.22	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	160.05	151.13	15.32	1.49	12.94	14.43	1.49	0.15	1.49
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	135.69	143.67	12.97	1.40	14.17	10.78	2.39	0.00	2.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	215.69	242.55	18.32	0.83	20.20	13.74	2.29	0.21	1.46
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	350.96	401.97	18.30	2.52	40.72	33.17	4.35	0.00	3.43
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	299.72	359.89	19.23	1.81	42.30	24.88	2.94	0.00	1.58
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	285.88	332.58	16.59	1.31	44.08	28.81	3.49	0.00	2.18
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	271.41	357.76	16.68	2.15	37.12	51.11	9.68	0.00	1.08
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	296.93	379.80	15.53	1.92	33.85	63.50	5.76	0.17	2.27
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	321.93	469.22	16.41	3.79	47.13	83.74	6.73	0.42	3.37
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	297.61	351.81	11.94	1.65	33.99	28.29	3.86	0.18	0.73
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	236.02	241.30	15.85	3.52	28.89	22.54	1.76	0.00	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	261.04	340.45	11.85	2.19	29.83	30.71	3.51	0.00	2.19
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	255.46	361.13	17.96	2.27	31.91	53.01	7.15	0.17	1.57
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	277.27	366.47	16.35	1.86	36.05	42.74	5.20	0.00	2.23
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	375.06	673.16	25.00	2.16	57.55	80.40	11.21	0.00	1.51
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	350.52	365.67	15.15	0.82	33.58	20.06	3.69	0.41	2.87
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	255.67	360.91	14.37	1.39	35.70	30.37	2.32	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	366.08	489.27	11.37	1.86	51.27	45.24	6.26	0.00	1.39
CD14+CD16+ Monocytes, donor1	11789-124B7	39.67	70.40	10.24	0.44	2.62	6.54	0.00	0.00	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	49.43	84.31	15.25	0.00	5.54	5.77	0.46	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	49.39	92.71	9.31	0.65	4.98	6.93	0.22	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	91.72	114.46	17.29	1.25	6.07	8.88	0.78	0.00	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	100.94	117.71	13.27	1.57	5.76	8.38	0.35	0.00	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	94.98	145.60	15.61	1.78	6.47	7.80	0.45	0.00	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	12.50	29.09	10.46	0.26	1.02	4.34	0.00	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	13.17	34.47	10.98	0.44	1.76	1.76	0.66	0.00	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	18.53	48.43	11.16	0.84	1.26	5.05	0.84	0.00	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	8.13	6.10	28.45	0.00	0.00	0.00	0.00	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	17.63	10.85	21.70	0.00	0.68	1.36	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	13.46	12.43	26.93	0.00	0.00	2.07	0.00	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	22.39	21.85	15.99	0.00	0.00	0.53	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	16.62	9.11	20.91	0.54	1.07	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	15.44	11.23	16.85	1.40	0.70	0.70	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	14.90	18.04	19.61	0.78	0.00	0.78	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	18.46	15.82	21.09	0.00	1.32	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	3.29	1.64	6.58	0.00	0.82	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	9.43	2.90	7.25	0.00	0.73	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	7.57	4.54	7.07	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	27.48	8.08	34.75	8.49	0.40	0.00	3.64	2.83	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	21.17	5.59	23.97	7.19	0.40	0.40	2.80	1.20	0.00
CD34+ Progenitors, donor1	11545-120B6	21.09	6.02	11.04	1.00	1.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	100.00	38.20	10.67	1.69	5.06	1.12	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	25.18	20.67	12.40	1.50	0.75	1.88	0.00	0.75	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	24.80	21.20	13.75	2.93	1.35	0.23	0.00	1.80	0.00
CD4+ T Cells, donor1	11225-116C1	2.14	2.50	5.71	0.36	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	4.29	0.00	3.06	0.00	0.00	0.00	0.00	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	4.27	1.52	4.88	0.00	0.00	0.30	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	2.81	8.93	14.55	0.26	0.26	1.02	0.00	0.00	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	3.59	6.74	12.35	0.00	0.22	0.67	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	4.89	10.35	15.81	0.57	0.29	0.29	0.00	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	5.69	3.79	18.96	0.47	0.95	0.47	0.00	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	9.83	4.21	23.18	0.70	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	6.59	3.30	19.78	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	4.34	2.31	8.96	0.72	0.14	0.00	0.14	0.14	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	4.91	2.71	8.98	1.19	0.68	0.34	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	5.96	3.87	8.22	0.81	0.48	0.32	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	4.48	1.79	10.76	0.90	0.45	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	4.89	1.75	9.08	2.10	0.35	0.00	0.00	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	7.04	0.88	12.32	0.88	0.44	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	9.70	4.64	24.46	2.11	0.84	0.42	0.00	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	19.11	13.09	23.06	2.29	1.45	0.42	0.00	0.42	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	9.69	7.35	16.04	1.34	0.67	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	4.89	1.90	16.04	0.27	0.27	0.27	0.27	0.27	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	8.58	3.75	16.08	1.07	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	5.38	0.00	7.17	0.00	1.79	1.79	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	6.12	6.49	19.66	0.56	0.56	0.19	0.00	0.00	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	6.50	5.42	15.38	1.08	0.43	0.00	0.00	0.22	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	5.04	4.83	7.15	0.84	0.42	0.21	0.00	0.21	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	6.07	5.56	16.18	1.01	0.51	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	8.23	3.03	19.93	1.73	0.87	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	13.07	6.97	18.30	0.44	0.87	0.00	0.00	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	7.92	6.43	28.21	0.49	0.00	0.00	0.49	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	2.77	5.54	23.08	1.85	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	12.56	8.37	23.73	0.00	1.40	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	12.46	13.57	28.52	1.11	0.55	0.83	0.00	0.28	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	14.23	10.06	34.35	0.49	1.23	0.25	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	26.18	13.86	29.26	0.00	0.00	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	16.83	16.47	29.01	1.07	0.36	1.79	0.36	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	8.31	8.31	37.39	1.38	2.77	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	7.53	5.24	13.75	0.33	0.65	0.00	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	4.88	1.88	7.51	0.75	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	7.07	3.53	10.10	0.50	0.50	0.00	0.00	0.25	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	4.36	1.61	5.96	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	2.88	2.64	3.35	0.00	0.24	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	2.74	2.46	3.28	0.27	0.27	0.00	0.27	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	2.10	3.30	6.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	2.88	2.16	3.36	0.00	0.24	0.24	0.00	0.00	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	2.96	1.82	4.09	0.00	0.23	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	2.61	1.74	3.26	0.00	0.22	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	3.42	0.79	4.74	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	2.81	2.81	5.16	0.23	0.00	0.23	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	4.23	3.02	4.83	0.30	0.60	0.30	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	5.81	1.45	5.52	0.00	0.00	0.00	0.29	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	2.93	4.80	5.06	0.53	0.53	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	1.31	3.50	3.06	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	4.55	1.82	2.73	0.00	0.91	0.46	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	2.24	2.98	5.22	0.00	1.49	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	2.16	2.88	3.24	0.00	0.36	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	2.30	2.30	3.16	0.00	0.29	0.29	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	2.59	2.36	4.24	0.00	0.24	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	2.85	3.80	6.02	0.00	0.32	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	4.61	3.69	4.00	0.00	0.92	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	3.85	2.24	4.49	0.32	0.64	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	1.15	2.68	4.21	0.00	0.38	0.38	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	3.15	2.36	3.15	0.00	0.39	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	2.27	2.27	4.54	0.00	1.51	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	6.42	5.62	7.23	0.00	2.41	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	9.09	6.29	9.09	0.70	0.70	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	6.01	4.01	5.01	0.00	1.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	65.80	47.52	29.24	1.83	5.48	0.00	5.48	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	47.43	15.81	19.76	4.45	2.96	0.00	0.99	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	22.41	10.73	21.05	3.37	0.95	0.21	1.68	0.63	0.00
Chondrocyte - de diff, donor1	11261-116G1	4.85	2.43	6.59	1.73	0.35	0.00	0.69	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	4.62	1.42	4.26	0.36	0.36	0.00	1.07	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	7.28	3.98	10.24	0.68	0.68	0.57	0.57	0.34	0.11
Chondrocyte - re diff, donor2	11339-117F7	10.74	6.27	6.27	0.90	0.00	0.00	1.79	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	19.82	6.87	14.96	0.00	1.21	0.00	0.40	0.81	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	14.12	4.02	17.67	2.07	0.80	0.00	0.11	0.11	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	9.41	1.07	9.83	1.28	0.43	0.00	0.00	0.21	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	6.55	1.86	8.14	0.62	0.53	0.09	0.18	0.18	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	33.93	19.44	12.75	2.48	3.12	1.19	1.38	0.46	0.28
Corneal Epithelial Cells, donor1	11526-119I5	3.95	0.88	1.98	0.66	0.22	0.00	0.44	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	3.41	1.14	3.41	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	5.37	2.05	3.58	0.51	0.51	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	0.00	0.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	0.32	0.32	0.63	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	1.08	1.19	0.22	0.00	0.11	0.11	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	28.01	13.32	9.91	1.37	1.02	0.68	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	123.39	56.15	7.83	6.53	5.88	1.96	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	36.78	17.42	12.58	0.48	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	18.18	6.00	8.17	2.00	0.33	0.00	0.00	0.33	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	9.39	3.52	5.28	0.59	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	11.59	3.39	12.44	0.85	0.57	0.28	0.00	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	16.51	5.11	7.47	0.79	0.79	0.00	0.00	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	4.65	2.04	3.20	2.04	0.00	0.00	0.00	0.58	0.29
Endothelial Cells - Artery, donor2	11341-117F9	11.06	2.59	5.18	1.41	0.24	0.00	0.00	0.00	0.47
Endothelial Cells - Artery, donor3	11413-118E9	10.69	3.16	6.49	2.28	0.35	0.00	0.00	0.53	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	20.61	7.09	8.64	1.77	0.44	0.22	0.00	0.22	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	42.29	18.86	13.39	4.87	1.22	0.61	0.61	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	41.16	22.83	15.79	3.10	0.85	0.00	0.00	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	7.73	2.67	2.97	0.00	0.00	0.59	0.30	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	13.54	3.12	8.33	0.52	0.00	0.00	0.52	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	13.33	5.53	7.51	0.71	0.28	0.00	0.28	0.43	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	22.81	10.80	7.20	2.00	0.80	0.00	0.00	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	9.43	1.05	3.14	0.00	0.00	0.00	0.00	1.05	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	37.52	19.26	13.29	4.47	0.87	0.37	0.00	0.99	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	26.94	11.95	8.47	2.39	1.09	0.00	0.00	1.09	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	31.63	17.22	10.01	3.66	0.49	0.37	0.00	0.85	0.24
Endothelial Cells - Vein, donor1	11267-116G7	4.55	1.14	5.69	0.00	1.14	0.00	0.00	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	4.19	3.49	6.29	3.49	1.40	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	8.79	3.77	4.40	1.26	0.16	0.16	0.00	0.47	0.00
Eosinophils, donor1	12244-129H3	0.00	15.25	45.74	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	57.76	103.97	26.40	0.00	3.30	6.60	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	156.94	192.61	32.10	0.00	10.70	14.27	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	2.93	0.98	3.18	0.24	0.24	0.00	0.24	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	0.00	2.08	0.00	0.00	0.00	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	6.16	1.64	6.98	0.82	0.00	0.41	0.00	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.18	0.55	3.61	0.44	0.33	0.00	0.44	0.00	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	13.11	5.63	10.83	1.73	1.30	0.22	0.98	0.76	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	13.46	4.12	11.89	2.18	0.49	0.12	0.85	0.24	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	5.60	3.14	10.92	2.73	0.55	0.14	1.09	0.27	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	8.12	3.16	9.07	1.16	0.84	0.00	0.42	0.53	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	18.97	6.06	17.92	1.58	1.32	0.79	1.32	1.05	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	15.61	6.31	12.96	3.32	1.99	0.00	1.33	0.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	2.72	2.72	7.71	2.27	0.45	0.00	0.45	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	3.79	0.00	3.03	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	5.20	1.42	3.79	0.47	0.47	0.00	0.32	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	41.22	16.37	31.52	5.46	3.64	0.61	1.52	0.61	0.00
Fibroblast - Cardiac, donor5	11456-119A7	21.70	10.66	16.12	2.03	1.65	0.38	0.51	0.63	0.51
Fibroblast - Cardiac, donor6	11460-119B2	42.90	22.74	17.13	3.34	1.36	1.97	1.06	0.15	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	15.01	11.39	12.73	1.07	1.47	0.40	0.80	0.00	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	22.87	13.81	9.06	1.29	2.16	0.00	0.86	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	2.93	1.46	8.79	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	11.99	3.69	6.23	0.69	0.69	0.23	0.46	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	17.47	4.92	15.77	2.20	0.68	0.00	1.87	0.34	0.00
Fibroblast - Dermal, donor1	11269-116G9	2.35	1.41	4.23	0.47	0.23	0.00	0.70	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	5.66	2.36	7.08	0.94	0.47	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	5.68	2.18	8.22	1.69	0.12	0.12	0.12	0.60	0.12
Fibroblast - Dermal, donor4	11450-119A1	8.82	1.58	10.74	1.92	0.45	0.11	0.23	0.79	0.23
Fibroblast - Dermal, donor5	11454-119A5	8.02	2.09	12.56	2.27	0.87	0.00	0.00	0.87	0.17
Fibroblast - Dermal, donor6	11458-119A9	11.86	1.79	18.19	2.76	0.49	0.16	0.32	1.14	0.00
Fibroblast - Gingival, donor1	11237-116D4	12.91	7.50	17.28	0.83	1.25	0.21	1.04	0.00	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	6.81	2.36	4.45	1.31	0.26	0.00	0.52	0.52	0.00
Fibroblast - Gingival, donor2	11318-117D4	9.22	2.50	10.41	2.64	0.79	0.13	0.13	1.19	0.00
Fibroblast - Gingival, donor3	11394-118C8	19.53	7.83	22.14	1.93	1.35	0.10	1.93	0.29	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	164.15	39.48	15.58	5.19	5.19	1.04	0.00	0.00	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	64.67	12.69	8.81	1.76	3.17	0.70	0.35	0.53	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	17.46	5.30	8.73	4.52	0.94	0.00	0.31	0.78	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	10.82	2.30	6.76	1.89	0.68	0.00	0.27	0.27	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	6.35	0.71	3.53	2.47	0.00	0.00	0.00	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	10.09	2.49	7.90	2.49	0.44	0.29	0.29	0.29	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	13.09	3.27	9.82	2.05	0.27	0.27	0.00	0.68	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	10.31	3.29	8.34	2.63	0.55	0.11	0.22	0.88	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	15.85	5.43	17.61	1.47	1.47	0.29	0.88	0.15	0.59
Fibroblast - Lung, donor1	11270-116H1	14.95	2.72	8.16	4.08	0.00	0.00	1.36	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	22.38	10.45	22.38	0.00	4.48	0.00	2.98	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	18.36	5.91	15.83	3.38	0.42	0.21	0.63	1.06	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	4.17	2.50	9.16	0.00	1.67	0.00	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	5.59	0.00	12.59	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	1.40	0.56	3.92	0.28	0.28	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	9.34	5.28	15.83	2.44	1.62	0.00	0.81	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	7.99	0.00	7.99	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	5.96	17.87	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	10.28	3.49	16.49	2.52	0.19	0.00	0.39	0.78	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	11.38	1.52	13.65	1.82	0.46	0.00	0.15	0.91	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	8.87	4.90	16.83	3.06	0.00	0.00	0.31	1.22	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	7.25	1.14	6.11	0.38	1.14	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	3.24	2.70	8.10	0.81	0.00	0.00	0.27	0.54	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	65.41	16.47	9.97	3.60	4.18	0.46	0.81	0.46	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	25.86	8.51	14.81	5.08	0.77	0.33	0.66	0.22	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	9.75	3.45	10.97	1.42	1.63	0.41	0.00	0.41	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	8.02	1.34	8.69	0.00	0.67	0.00	0.67	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	14.23	3.95	12.65	0.79	0.40	0.79	0.79	0.79	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	5.95	1.39	7.74	0.99	0.79	0.00	0.20	0.99	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	4.09	2.84	7.82	0.71	0.18	0.00	0.53	0.18	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	5.91	3.15	10.25	1.77	0.39	0.00	1.18	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	4.51	1.20	8.42	1.50	0.30	0.00	0.00	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	6.26	2.16	8.31	0.86	0.22	0.22	0.86	0.43	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	6.07	1.52	11.14	1.52	0.25	0.25	0.00	0.51	0.00
Fibroblast - skin normal, donor1	11553-120C5	4.59	1.48	4.92	0.66	0.33	0.16	0.16	0.00	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	5.21	2.01	7.02	1.60	0.80	0.00	0.00	0.60	0.00
Fibroblast - skin normal, donor2	11561-120D4	3.42	1.91	5.53	0.60	0.50	0.00	0.40	0.20	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	12.69	1.81	12.09	3.02	0.30	0.60	0.00	1.21	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	9.61	3.23	15.33	2.32	0.58	0.00	1.57	0.33	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	12.14	5.64	17.61	1.20	0.68	0.34	2.39	0.34	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	2.96	0.66	5.58	0.33	0.00	0.00	0.00	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	2.66	0.53	4.58	0.53	0.00	0.11	0.21	0.00	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	3.37	1.52	3.20	0.84	0.17	0.00	0.00	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	2.67	2.51	4.86	0.63	0.16	0.16	0.31	0.31	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	22.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	29.63	8.72	6.10	1.74	1.74	0.87	0.00	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	23.75	7.11	12.83	3.47	0.87	0.17	1.39	0.35	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	33.57	4.94	11.71	2.34	1.30	0.00	0.52	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	23.51	8.43	10.73	3.32	0.77	0.51	1.28	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	11.48	1.53	15.31	2.30	0.77	0.00	0.77	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	8.29	2.55	22.97	2.55	0.64	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	15.97	3.42	63.90	5.42	0.86	0.00	0.57	1.43	1.43
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	1.65	0.55	7.17	0.00	0.00	0.00	0.00	0.00	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	2.97	1.83	7.53	0.68	0.23	0.00	0.23	0.23	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	9.71	1.39	35.86	3.76	0.40	0.00	2.38	0.79	1.39
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	1.06	0.79	8.19	0.79	0.26	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	3.91	0.65	3.26	0.00	0.65	0.00	0.00	0.33	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	8.84	2.21	29.63	3.54	0.00	0.00	1.33	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	7.77	2.54	57.24	2.97	0.85	0.28	1.70	0.99	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	11.70	3.08	47.53	3.45	0.86	0.37	1.23	0.49	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	11.28	3.49	42.98	2.69	0.54	0.00	1.88	1.07	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	7.19	4.71	27.26	1.61	0.99	0.00	0.62	0.25	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	8.72	3.18	30.59	1.94	0.14	0.00	0.14	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	13.62	2.44	30.09	3.66	0.41	0.00	1.22	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	10.72	3.88	18.71	3.19	0.23	0.46	0.91	0.00	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	9.84	3.99	24.29	1.62	0.50	0.12	0.37	0.87	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	13.77	4.81	25.57	3.72	0.66	0.00	0.66	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	12.71	1.77	20.39	2.36	0.00	0.00	0.89	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	10.01	3.97	25.75	1.59	1.11	0.16	1.27	0.16	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	15.64	4.02	40.89	3.80	0.22	0.00	1.34	0.67	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	7.26	1.81	14.32	1.41	0.20	0.20	0.60	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	10.69	3.56	17.98	1.36	0.34	0.00	0.85	0.51	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	24.21	6.83	30.06	4.08	1.51	0.09	1.33	0.18	0.53
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	6.04	1.56	15.09	1.56	0.21	0.10	0.42	0.31	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	5.29	1.71	14.69	1.71	0.17	0.00	0.17	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	5.86	1.99	15.38	1.44	0.33	0.00	0.22	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	16.47	6.16	20.72	3.16	0.83	0.33	0.25	0.58	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	17.15	4.70	17.76	2.45	2.04	0.41	0.41	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	7.43	1.24	10.11	0.62	0.21	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	4.27	1.38	13.14	0.69	0.12	0.00	0.35	0.69	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	14.68	5.67	10.17	1.33	1.33	0.00	0.33	0.50	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	2.87	2.65	10.80	0.88	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	5.41	2.71	13.53	0.74	0.12	0.00	0.12	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	16.70	7.62	12.97	1.62	1.13	0.49	0.16	0.16	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	7.70	1.60	10.90	0.96	0.32	0.00	0.00	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	6.06	2.84	11.09	0.95	0.09	0.19	0.00	0.19	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	15.82	6.49	7.28	1.27	1.42	0.32	0.00	0.79	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	11.25	1.52	8.51	0.61	0.61	0.00	0.00	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	6.17	3.45	8.26	1.05	0.31	0.21	0.00	0.10	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	23.71	9.44	12.73	1.32	0.66	0.44	0.44	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	9.26	2.52	5.89	0.56	0.28	0.00	0.00	0.56	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	5.83	2.41	8.06	1.02	0.56	0.00	0.19	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	29.95	9.09	10.96	1.07	2.41	0.27	0.00	0.27	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	10.86	4.44	6.73	1.07	0.61	0.15	0.15	0.46	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	10.36	6.35	8.81	1.42	1.42	0.13	0.13	0.13	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	31.44	13.28	13.28	3.52	1.63	0.27	0.00	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	7.37	2.03	9.40	0.37	0.18	0.00	0.18	0.74	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	5.48	1.75	7.46	0.66	0.00	0.00	0.22	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	15.87	4.96	16.86	0.00	1.98	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	4.62	1.32	5.67	1.71	0.00	0.13	0.13	0.13	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	4.84	1.61	7.06	1.01	0.00	0.00	0.00	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	11.95	3.30	28.47	2.03	0.51	0.00	0.76	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	8.16	3.98	49.37	1.99	1.00	0.00	1.19	0.60	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	6.01	1.54	62.09	2.16	0.00	0.31	0.77	0.31	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	7.77	4.50	67.92	4.30	0.41	0.41	0.61	2.25	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	3.44	0.63	12.52	0.31	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	2.26	0.57	11.30	1.70	0.00	0.00	0.00	0.57	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	2.77	1.38	10.61	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	4.95	0.00	7.42	2.47	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	3.48	1.93	11.60	1.93	1.16	0.00	0.77	0.00	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	4.81	4.81	14.44	0.00	1.60	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	8.69	1.74	13.91	1.74	0.00	0.00	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	6.51	1.30	14.32	0.65	0.00	0.33	0.65	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	5.77	2.47	18.94	3.71	0.41	0.00	0.41	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	3.33	0.00	13.33	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	6.15	1.96	10.63	2.24	0.00	0.00	1.40	0.28	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	5.56	0.98	11.11	1.63	0.65	0.00	0.65	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	3.36	1.68	7.55	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	4.45	2.54	7.32	1.59	0.00	0.00	0.64	0.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	3.40	1.36	9.17	1.02	0.34	0.00	0.00	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	2.09	8.35	10.44	0.00	0.00	0.00	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	2.86	1.72	8.59	0.00	0.00	0.00	0.57	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	2.37	0.89	5.92	0.30	0.00	0.00	0.00	0.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	1.69	0.00	8.47	1.69	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	4.56	1.66	9.11	1.24	0.00	0.00	0.00	0.83	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	4.37	3.22	3.91	0.92	0.00	0.46	0.00	0.23	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	5.27	0.00	26.34	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	6.54	2.31	3.84	0.38	0.00	0.00	0.00	0.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	5.22	2.28	5.54	0.33	0.00	0.00	0.00	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	6.02	0.67	4.01	0.67	0.67	0.00	0.67	1.34	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	5.01	0.77	8.09	0.77	0.00	0.00	0.00	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	4.79	2.74	5.48	0.68	0.34	0.00	0.34	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	9.94	2.48	2.48	2.48	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	2.83	0.47	8.97	1.42	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	4.83	0.60	4.22	1.21	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	2.54	0.51	3.56	1.53	0.51	0.00	0.00	1.02	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	4.39	2.39	6.38	1.99	0.00	0.00	0.00	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	5.43	1.97	5.92	0.00	0.49	0.00	0.00	0.00	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	7.08	4.72	4.72	1.18	0.00	0.00	0.00	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	4.08	2.33	4.67	2.33	0.00	0.00	0.00	0.58	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	4.39	2.63	3.07	0.00	0.44	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	4.24	0.00	2.54	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	2.39	1.19	0.00	0.60	0.60	0.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	4.37	1.46	4.85	0.49	0.97	0.00	0.00	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	87.88	17.12	5.71	4.57	6.85	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	19.96	4.57	5.82	1.25	2.91	0.00	0.00	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	3.37	0.00	2.25	2.25	0.00	0.00	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	16.81	8.56	13.00	2.54	1.27	0.63	1.59	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	15.46	2.51	9.61	3.34	0.84	1.25	0.42	0.84	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	16.59	5.11	4.41	3.71	1.16	0.12	0.23	0.00	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	21.94	4.56	3.88	2.53	1.52	0.00	0.17	0.17	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	16.61	3.19	4.55	2.28	0.68	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	19.35	5.03	5.03	2.95	1.20	0.22	0.00	0.98	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	19.77	3.44	4.94	3.01	1.29	0.21	0.00	1.07	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	16.15	5.38	4.74	3.23	1.51	0.22	0.00	0.43	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	18.81	3.86	4.98	3.11	0.75	0.12	0.00	0.62	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	17.15	4.46	5.32	2.57	1.37	0.00	0.34	0.51	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	8.65	4.49	4.16	4.49	1.28	0.00	0.32	0.64	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	15.67	11.75	2.24	0.00	0.56	0.00	0.00	0.56	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	4.76	2.60	1.73	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	21.15	2.64	7.93	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	3.17	1.76	6.35	1.06	0.00	0.00	0.00	0.71	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	1.45	1.45	5.81	0.00	0.73	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	21.33	11.36	6.99	1.75	1.75	0.35	0.52	0.17	0.00
Hepatocyte, donor1	11523-119I2	38.74	19.37	12.11	0.00	8.47	1.21	3.63	0.00	0.00
Hepatocyte, donor2	11603-120I1	63.56	58.18	14.01	3.23	12.93	3.23	5.39	1.08	2.15
Hepatocyte, donor3	11684-122I1	41.11	46.63	11.04	1.23	4.91	2.45	1.23	1.23	1.84
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	10.44	3.26	5.87	5.22	0.65	0.00	0.00	1.31	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	46.32	11.01	10.66	4.02	1.57	0.17	0.35	0.35	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	4.80	1.92	5.35	0.69	0.27	0.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	6.37	0.00	19.10	0.00	0.00	0.00	0.00	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	6.68	20.03	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	27.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	9.69	2.77	2.77	1.38	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	0.00	7.51	2.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	47.47	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	10.25	0.00	12.81	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	0.00	18.28	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	14.62	3.25	17.87	3.25	0.00	0.00	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	3.33	0.00	13.34	5.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	3.63	7.26	3.63	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	7.94	1.32	21.18	2.65	0.00	0.00	0.00	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	4.43	2.22	16.63	4.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00	10.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	6.30	2.52	14.49	5.04	0.00	0.00	0.00	1.26	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	3.09	1.55	26.29	1.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	43.90	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	3.88	3.23	16.80	1.29	0.65	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	8.05	0.00	8.05	1.61	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	11.95	0.00	11.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	13.85	1.63	28.52	1.63	0.00	0.00	0.00	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	3.36	1.26	15.95	0.42	0.42	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	14.37	14.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	9.64	1.61	20.90	5.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	4.62	0.92	7.39	0.00	0.92	0.00	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	15.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	4.25	1.89	9.91	0.47	0.00	0.00	0.00	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	3.63	2.72	11.79	1.81	0.00	0.00	0.00	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	14.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	10.76	0.00	16.14	2.15	0.00	0.00	0.00	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	0.00	2.54	13.98	0.00	2.54	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	16.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	4.46	0.64	8.29	0.64	0.00	0.00	0.00	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	1.82	1.82	7.29	3.65	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	47.41	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	2.86	3.57	13.57	6.43	0.00	0.71	0.00	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	3.32	0.00	6.64	3.32	0.00	0.00	0.00	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	7.10	1.54	12.96	2.16	0.31	0.00	0.31	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	7.02	1.76	14.05	3.51	0.00	0.00	0.00	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	0.00	12.57	0.00	0.00	0.00	3.14	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	13.21	2.78	10.43	4.87	0.00	0.00	0.00	2.09	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	15.49	0.00	17.70	2.21	0.00	0.00	0.00	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	3.24	19.45	6.48	0.00	0.00	0.00	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	5.23	1.74	23.54	1.74	0.00	0.00	1.74	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	11.25	4.50	13.50	2.25	0.00	0.00	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	3.48	24.39	0.00	0.00	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	10.67	1.07	22.40	1.07	0.00	0.00	0.00	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	4.16	0.00	8.31	1.39	0.00	0.00	0.00	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	5.70	0.00	17.10	2.85	2.85	0.00	2.85	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	6.44	0.92	25.77	0.92	0.92	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	18.15	3.03	15.13	3.03	0.00	0.00	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	6.21	18.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	5.29	5.29	17.98	6.34	0.00	0.00	1.06	2.11	0.00
Keratinocyte - epidermal, donor1	11272-116H3	5.47	1.88	6.04	0.82	0.65	0.08	0.24	0.08	0.08
Keratinocyte - epidermal, donor2	11349-117G8	4.69	1.76	4.10	0.59	1.76	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	65.69	8.33	5.40	4.54	2.56	0.09	0.28	0.09	0.19
Keratinocyte - oral, donor1	11251-116E9	27.81	6.81	15.10	4.65	0.79	0.00	0.11	0.23	0.23
Keratocytes, donor1	11527-119I6	93.52	24.41	6.88	2.75	5.50	0.34	0.00	0.00	0.34
Keratocytes, donor2	11607-120I5	4.69	2.34	9.37	1.17	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	167.56	37.94	5.93	4.15	7.90	0.40	0.79	0.00	1.58
Krukenberg tumor cell line:HSKTC	10687-109F3	30.77	13.19	6.59	8.79	0.00	0.00	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	4.31	2.16	5.39	0.00	1.08	0.00	0.00	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	4.73	0.69	15.45	0.92	0.12	0.00	0.23	0.23	0.00
Lens Epithelial Cells, donor3	11690-122I7	4.34	1.21	9.49	1.11	0.20	0.00	0.30	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	47.43	29.05	8.42	1.42	1.42	0.83	0.36	0.47	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	44.93	16.74	5.58	1.40	2.23	0.84	0.00	0.00	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	59.19	31.80	11.49	1.73	1.89	1.73	0.94	0.31	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	47.32	13.98	8.07	0.54	2.15	2.15	1.61	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	40.34	19.23	7.25	1.58	1.58	1.26	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	33.21	15.53	8.19	1.19	1.19	1.19	0.54	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	51.30	22.57	8.62	1.64	1.64	0.82	0.00	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	30.59	12.39	6.07	0.51	1.52	0.76	0.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	29.42	14.78	6.90	1.55	0.70	0.99	0.84	0.00	0.70
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	39.16	15.43	5.14	0.40	1.58	1.19	0.79	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	46.92	18.61	6.98	1.55	2.33	1.16	0.78	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	19.63	9.07	4.44	1.30	0.37	0.56	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	39.02	18.12	7.32	1.05	1.05	0.70	0.70	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	34.35	16.70	4.77	2.39	1.19	1.43	0.72	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	32.96	12.50	7.00	0.82	1.37	0.41	1.10	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	36.03	16.94	8.62	1.23	2.46	0.92	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	32.42	12.78	3.43	0.94	0.94	0.62	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	35.32	15.19	8.23	1.83	0.91	0.37	0.55	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	33.57	15.47	7.24	0.99	1.32	0.33	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	29.29	12.89	4.69	0.59	2.05	0.59	0.29	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	32.11	11.70	4.98	0.75	1.00	0.50	0.50	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	42.19	18.91	5.33	1.45	0.97	0.00	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	42.82	17.50	6.46	2.42	1.62	1.35	1.08	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	35.73	14.38	7.27	1.51	2.12	0.45	0.61	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	42.51	10.37	7.26	2.07	1.04	1.04	1.04	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	47.11	17.38	6.49	1.05	2.30	1.26	0.84	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	29.17	10.83	6.01	0.75	1.80	0.60	0.60	0.00	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	31.64	16.51	3.44	2.06	0.00	2.06	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	34.43	13.36	5.27	1.13	0.56	0.38	0.19	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	23.96	8.91	7.95	1.17	0.85	0.53	0.42	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	27.62	6.78	6.30	0.97	0.97	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	26.79	10.59	7.61	0.66	1.65	0.66	0.33	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	29.49	11.15	5.20	0.99	0.74	0.87	0.62	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	48.87	18.14	10.37	0.74	3.70	0.74	1.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	35.83	12.11	8.40	0.74	1.73	0.00	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	22.96	8.94	5.64	0.82	0.69	0.55	0.69	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	40.20	15.76	13.19	1.61	1.29	0.32	0.64	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	38.95	13.39	8.52	0.91	2.13	0.61	1.22	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	36.81	17.50	11.62	2.10	1.54	0.84	0.42	0.28	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	26.31	11.38	9.24	1.78	2.13	1.07	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	20.85	6.30	5.82	0.00	0.48	0.48	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	24.90	10.43	4.51	0.78	0.47	0.62	0.31	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	34.74	11.82	10.03	1.07	0.36	0.36	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	23.85	10.45	7.84	0.33	0.98	0.33	0.98	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	24.72	11.77	6.12	1.41	0.47	0.71	0.71	0.94	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	31.31	18.07	10.27	1.36	0.87	0.62	0.12	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	13.57	5.63	4.61	1.28	1.02	0.26	0.26	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	24.17	18.50	6.27	0.90	1.19	1.19	0.00	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	2.27	0.00	2.27	2.27	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	10.74	3.84	6.90	1.53	0.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	9.65	2.23	3.71	0.00	1.48	0.00	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	7.19	0.85	5.08	1.27	0.00	0.00	0.42	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	9.85	0.70	3.52	2.81	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	14.94	0.93	1.87	0.93	0.93	0.00	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	7.21	0.00	5.67	1.03	0.52	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	4.76	1.19	2.38	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	10.18	1.36	3.85	2.04	0.68	0.00	0.00	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	11.05	4.07	4.65	3.78	0.58	0.29	0.29	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	12.60	4.05	4.05	3.15	0.00	0.00	0.00	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	9.62	0.95	5.28	1.90	0.14	0.00	0.00	0.41	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	7.70	1.54	4.11	1.03	0.00	0.00	0.00	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	13.06	1.41	5.65	4.94	0.35	0.00	0.00	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	9.33	1.33	6.00	1.33	0.00	0.00	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	11.72	3.06	7.13	2.55	0.00	0.51	0.00	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	13.07	3.20	4.54	4.54	0.53	0.00	0.00	0.80	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	12.09	3.21	3.59	2.27	1.13	0.00	0.19	0.19	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	14.73	2.45	3.68	0.00	0.00	0.00	0.00	2.45	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	6.52	0.00	1.63	2.45	0.82	0.00	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	15.83	2.08	4.37	2.71	1.46	0.00	0.00	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	12.05	3.36	4.76	1.12	0.56	0.00	0.00	0.28	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	12.36	3.09	4.12	2.06	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	16.55	3.77	5.81	3.77	1.16	0.00	0.58	0.87	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	17.04	4.19	6.28	2.09	0.60	0.00	0.30	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	8.85	3.32	6.64	1.66	1.11	0.55	0.00	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	8.84	1.77	5.66	1.77	0.35	0.00	0.00	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	14.01	4.79	3.69	2.58	0.74	0.00	0.00	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	12.66	0.00	6.91	2.30	0.00	0.00	1.15	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	13.82	2.69	6.14	3.07	1.54	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	14.15	4.53	6.79	5.66	0.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	17.23	0.82	4.92	4.10	0.00	0.00	0.00	2.46	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	10.39	2.26	5.87	3.16	0.90	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	15.80	1.44	2.15	2.15	0.00	0.00	0.00	1.44	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	14.94	2.24	7.47	3.73	1.49	0.00	0.00	2.24	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	13.38	1.49	5.57	4.09	1.86	0.00	0.37	2.23	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	19.81	3.45	6.46	3.45	0.00	0.00	0.43	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	15.41	5.14	5.99	4.28	0.86	0.00	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	17.99	4.00	4.66	4.33	0.33	0.00	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	23.53	3.62	6.64	3.02	2.41	0.00	0.00	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	17.77	2.84	4.98	2.13	0.71	0.00	0.00	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	19.59	5.50	6.19	4.12	1.37	0.00	0.00	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	13.42	3.76	3.76	1.61	1.07	0.54	0.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	17.51	4.04	3.37	4.04	0.67	0.00	0.00	2.69	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	16.30	2.22	4.82	2.59	0.37	0.37	0.00	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	20.93	3.49	5.81	1.16	0.00	0.00	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	24.33	1.06	3.17	4.23	0.00	0.00	1.06	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	15.21	2.80	6.80	2.00	0.80	0.00	0.40	0.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	10.90	4.36	1.45	2.91	2.18	0.00	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	12.26	2.30	5.37	1.53	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	5.92	1.48	5.43	1.97	0.99	0.49	0.00	0.99	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	8.47	1.88	6.59	0.00	0.00	0.00	0.00	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	6.03	2.51	2.51	5.53	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	10.36	3.60	3.60	2.70	0.00	0.45	0.00	1.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	13.77	0.00	8.61	3.44	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	4.45	2.23	4.01	2.67	0.89	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	14.08	2.74	7.04	1.96	0.39	0.00	0.00	0.78	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	14.51	1.32	3.30	0.00	0.66	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	6.75	2.08	4.67	1.56	0.00	0.00	0.00	1.04	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	7.88	1.75	4.38	5.25	0.88	0.00	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	14.54	3.35	4.47	2.24	0.56	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	9.72	1.77	5.30	1.32	0.44	0.00	0.00	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	11.19	2.70	4.63	0.77	1.16	0.00	0.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	19.24	0.51	4.56	2.53	0.00	0.00	0.00	1.01	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	14.90	5.29	4.81	2.40	0.96	0.48	0.00	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	16.70	3.58	4.37	3.58	1.19	0.00	0.40	0.40	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	17.62	3.04	5.47	3.04	0.61	0.00	0.00	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	15.22	3.46	8.30	2.08	0.00	0.00	0.00	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	18.62	2.66	5.32	4.94	0.00	0.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	14.46	3.10	6.20	3.10	1.03	0.00	1.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	6.05	3.02	6.65	1.81	1.21	0.00	1.81	1.81	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	18.38	2.54	6.65	2.54	0.63	0.00	0.32	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	10.66	3.73	9.06	3.73	0.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	10.34	1.72	8.62	1.72	1.72	0.00	0.57	1.72	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	14.40	4.63	6.69	2.57	1.54	0.00	0.00	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	23.34	4.95	7.07	2.83	0.71	0.00	0.71	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	14.19	3.97	6.81	1.13	0.57	0.00	0.00	1.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	15.39	3.74	9.15	1.66	0.83	0.42	0.42	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	24.27	4.70	10.18	3.13	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	13.36	6.68	5.85	0.42	2.09	0.42	0.84	0.84	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	17.66	5.58	4.18	5.11	0.93	0.46	0.00	0.46	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	20.07	6.69	10.70	3.35	3.35	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	21.92	3.74	8.02	3.21	0.53	0.53	0.53	1.07	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	23.44	4.04	11.31	2.83	0.00	0.00	0.81	1.21	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	38.55	8.26	8.26	2.75	1.84	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	21.34	5.33	6.22	0.89	0.89	0.00	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	31.91	3.42	7.98	2.28	2.28	0.57	0.57	0.57	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	22.24	0.77	6.90	2.30	1.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	25.17	6.57	9.30	1.09	1.64	0.00	0.55	1.09	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	34.74	6.68	11.58	2.67	2.23	0.45	0.89	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	22.88	8.32	7.54	3.90	1.56	0.52	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	25.20	5.97	5.30	2.65	0.66	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	29.10	4.16	6.24	8.31	2.08	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	30.31	51.51	10.94	1.14	2.73	5.24	0.46	0.68	0.00
Macrophage - monocyte derived, donor2	11313-117C8	14.50	18.35	4.04	1.47	2.57	3.30	0.18	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	28.05	32.11	6.03	1.31	3.15	5.24	0.00	0.13	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	11.68	5.84	5.31	1.59	0.53	0.00	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	46.11	14.89	7.92	4.12	3.64	0.00	0.63	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	87.70	16.26	15.71	5.56	5.00	0.56	0.83	0.56	0.28
Mammary Epithelial Cell, donor1	11273-116H4	16.14	7.37	12.65	2.69	0.90	0.00	0.90	0.20	0.00
Mammary Epithelial Cell, donor2	11350-117G9	11.00	3.76	9.84	1.45	0.58	0.00	0.00	0.58	0.00
Mammary Epithelial Cell, donor3	11422-118F9	5.24	1.25	2.99	1.75	0.50	0.00	0.25	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	170.16	67.12	116.61	14.24	11.52	0.68	0.00	1.36	0.68
Mast cell, donor1	11563-120D6	19.47	7.25	17.84	3.03	0.43	0.22	0.11	0.54	0.00
Mast cell, donor2	11565-120D8	5.94	3.57	8.02	1.19	0.00	0.00	0.00	0.59	0.00
Mast cell, donor3	11566-120D9	20.04	6.75	31.07	3.83	0.23	1.58	0.45	1.35	0.23
Mast cell, donor4	11567-120E1	7.80	1.24	13.83	2.66	0.00	0.00	0.00	0.18	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	13.31	5.32	20.63	2.33	1.11	0.11	0.22	0.78	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	18.09	7.00	23.93	1.17	0.58	0.00	0.00	0.00	1.17
Mast cell, expanded, donor5	11939-126A4	10.10	2.75	20.19	3.33	0.00	0.11	0.00	1.03	0.46
Mast cell, expanded, donor8	11941-126A6	9.87	3.01	19.75	3.35	0.67	0.17	0.00	1.34	0.50
Melanocyte - dark, donor1	11502-119F8	54.72	17.61	30.74	3.58	1.19	0.90	1.39	0.99	0.20
Melanocyte - dark, donor2	11582-120F7	46.38	20.76	22.50	6.92	3.46	0.69	2.42	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	33.40	9.56	10.21	1.96	1.52	0.22	0.07	0.43	0.29
Melanocyte - light, donor1	11274-116H5	19.04	5.41	4.70	1.41	1.18	0.24	0.00	0.24	0.00
Melanocyte - light, donor2	11351-117H1	15.70	5.46	10.24	0.68	0.00	0.00	0.00	0.68	0.68
Melanocyte - light, donor3	11423-118G1	11.27	1.73	5.20	0.87	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	32.17	11.14	22.80	2.92	2.29	0.10	0.52	0.52	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	97.63	31.74	16.14	4.30	6.19	0.54	0.81	0.54	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	125.62	18.21	17.68	2.95	5.36	0.80	1.61	0.80	0.27
Meningeal Cells, donor1	11493-119E8	10.79	6.58	8.31	1.61	1.36	0.12	0.25	0.37	0.00
Meningeal Cells, donor2	11573-120E7	10.12	8.36	10.12	1.32	1.32	0.44	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	21.76	4.65	13.61	2.77	0.57	0.08	0.16	0.33	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	8.55	2.85	13.69	2.28	0.86	0.00	0.00	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	5.23	1.21	8.86	0.81	0.20	0.10	0.00	0.10	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	1.31	3.94	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	3.92	1.31	3.92	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	7.89	6.46	11.48	2.87	2.15	0.00	0.00	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	10.16	3.39	7.41	1.27	0.42	0.21	0.42	0.21	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	12.06	4.02	4.02	1.01	0.50	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	4.18	0.66	5.49	0.22	0.22	0.22	0.00	0.88	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	1.46	0.73	4.38	0.00	0.00	0.00	0.73	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	0.82	0.41	4.71	0.61	0.20	0.20	0.41	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	8.17	6.79	13.85	1.66	1.25	0.83	0.69	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	2.97	3.72	5.20	0.74	1.12	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	22.89	9.87	23.55	3.55	1.71	0.79	1.84	0.53	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	3.86	2.37	8.61	0.59	0.30	0.30	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	4.67	9.34	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	7.68	3.20	6.40	0.64	0.00	0.64	1.28	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	17.72	6.73	18.08	2.13	0.00	0.35	0.35	0.71	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	16.57	8.76	25.33	4.69	0.63	0.31	1.88	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	29.75	9.43	15.24	1.45	0.73	0.73	0.00	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	7.42	2.65	13.52	1.86	0.53	0.00	0.00	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	4.50	1.00	6.51	0.50	0.00	0.00	1.00	1.00	0.00
Mesothelial Cells, donor3	11402-118D7	7.08	2.24	7.80	1.08	0.43	0.07	0.51	0.22	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	16.20	5.40	8.10	2.70	0.00	0.00	0.00	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	18.47	15.27	5.91	0.74	1.23	0.74	0.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	9.42	6.48	7.07	1.47	1.18	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	20.74	0.00	6.91	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	15.19	15.50	5.58	0.62	1.55	1.24	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	11.20	8.30	5.19	0.62	1.45	0.62	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	25.48	4.63	2.32	0.00	2.32	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	20.27	17.77	6.26	0.25	2.50	1.75	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	17.22	6.98	7.45	0.47	1.40	1.86	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	20.12	17.68	2.44	1.22	0.41	1.83	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	17.03	9.11	3.96	0.00	1.58	1.19	0.79	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	17.10	0.00	0.00	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	20.35	4.42	0.88	0.00	2.65	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	14.44	8.36	4.18	0.76	0.00	1.14	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	50.00	34.21	7.90	1.32	2.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	39.26	20.37	3.18	0.21	4.03	0.85	0.64	0.21	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	23.02	13.81	1.84	0.00	4.60	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	71.83	30.10	2.98	1.79	5.66	1.49	0.89	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	28.50	23.47	1.68	1.68	3.35	8.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	67.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	115.16	51.94	3.26	1.00	11.54	4.52	1.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	72.01	36.13	4.52	2.38	4.75	2.85	0.71	0.00	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	147.07	48.65	5.53	4.42	11.06	3.87	1.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	146.44	97.39	3.45	1.61	18.42	5.53	1.15	0.46	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	79.09	35.76	3.16	1.68	6.31	2.10	0.21	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	203.01	111.90	4.48	2.45	24.26	8.56	1.02	0.41	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	114.13	75.52	3.43	1.29	12.01	5.58	0.64	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	114.92	56.02	3.33	2.67	11.34	2.67	0.89	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	123.82	72.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	192.95	107.54	5.26	1.53	18.18	7.45	0.66	0.22	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	125.73	43.09	5.58	2.53	6.59	5.07	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	200.50	57.99	0.00	0.00	18.23	3.31	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	259.56	125.84	3.53	1.90	28.27	8.70	1.63	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	157.63	76.46	4.12	1.18	21.47	6.18	1.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	189.72	56.70	2.18	1.09	7.63	2.18	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	177.81	124.94	5.29	1.92	24.03	8.65	1.44	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	200.91	100.86	3.20	1.60	21.61	8.81	1.60	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	264.64	138.49	4.11	2.74	39.77	6.86	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	210.74	130.65	2.00	0.50	25.53	11.01	1.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	377.26	107.79	26.95	0.00	0.00	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	207.93	169.20	2.04	2.04	24.46	6.12	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	296.91	196.63	3.07	3.07	34.60	21.46	3.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	199.76	99.33	3.31	0.00	14.35	3.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	249.11	146.65	1.28	3.20	17.29	3.84	1.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	279.65	206.27	3.72	1.49	29.50	19.59	1.98	0.00	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	189.98	72.37	2.09	3.48	18.79	4.18	0.70	0.70	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	229.83	141.43	4.42	0.00	19.89	8.84	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	245.81	191.79	5.13	2.39	20.17	16.41	1.03	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	205.68	75.71	2.19	1.75	21.44	2.63	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	217.32	127.12	3.55	1.42	24.15	6.39	1.78	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	255.30	188.53	5.05	2.52	24.69	16.27	1.40	0.28	1.68
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	206.57	91.85	1.66	7.07	19.12	7.90	1.25	0.42	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	213.87	139.86	2.91	3.50	14.57	4.08	1.17	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	192.16	135.45	4.83	3.62	19.00	13.88	2.41	0.30	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	181.57	90.57	3.34	3.34	19.62	9.18	1.67	1.67	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	259.88	158.81	14.44	0.00	21.66	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	246.59	134.84	0.92	2.77	25.86	11.08	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	252.69	108.13	5.12	5.69	29.03	10.24	2.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	186.82	138.87	6.08	3.45	18.65	9.12	1.38	0.14	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	235.31	165.08	6.22	2.59	22.81	15.03	2.85	0.26	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	257.81	130.41	3.86	3.86	24.88	6.86	1.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	228.03	118.78	2.54	4.45	22.87	5.08	1.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	253.81	134.25	7.21	4.27	19.48	11.74	1.60	0.27	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	196.96	121.23	13.17	5.39	23.35	15.27	2.99	0.30	1.20
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	162.58	115.26	6.92	2.83	14.41	7.63	2.97	0.57	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	251.63	164.67	3.50	2.23	27.39	18.16	3.19	0.32	1.59
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	239.71	127.37	5.31	6.19	23.00	10.39	3.76	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	230.17	149.78	5.69	4.55	18.96	6.83	0.38	0.76	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	261.95	154.84	7.67	3.41	20.17	10.23	3.13	0.57	1.70
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	210.90	130.03	5.65	4.92	25.81	10.57	3.20	0.00	1.23
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	203.97	127.08	5.87	3.26	19.55	12.38	1.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	216.70	132.02	11.76	3.23	17.05	15.00	3.82	0.00	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	173.28	119.66	9.23	4.32	17.30	10.38	3.17	0.29	1.44
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	172.69	138.48	15.25	4.53	17.31	14.01	4.95	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	194.15	150.98	7.74	2.98	20.25	14.59	2.68	0.60	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	22.60	22.60	0.00	0.00	0.00	7.53	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	16.04	8.91	3.56	0.00	1.78	1.78	0.00	3.56	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	41.73	46.33	2.63	1.97	3.29	1.97	0.33	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	12.62	19.99	1.05	1.05	4.21	1.05	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	13.24	21.75	4.94	0.40	0.40	0.59	0.20	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	25.15	16.76	2.79	0.93	1.86	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	22.91	23.28	3.76	3.38	1.88	2.25	0.00	0.38	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	7.72	8.52	1.60	0.27	0.53	0.27	0.27	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	32.46	53.04	4.41	0.57	4.64	4.41	0.23	0.00	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	29.47	22.84	4.42	0.00	2.21	1.47	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	24.55	31.15	2.56	0.37	2.20	2.20	0.37	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	21.78	17.11	3.11	0.00	4.67	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	88.18	114.90	3.21	0.53	10.15	13.90	0.53	0.53	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	50.23	27.05	0.00	0.00	3.86	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	48.48	32.32	1.01	4.04	5.05	2.02	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	39.63	33.73	1.26	1.69	2.53	2.95	0.00	0.00	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	156.62	193.40	6.81	0.00	25.88	17.71	8.17	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	224.44	186.92	3.81	0.64	27.34	13.35	1.27	0.00	1.27
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	242.14	260.77	5.67	3.24	34.01	28.34	0.81	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	61.93	75.52	4.53	1.51	7.55	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	502.49	422.55	5.71	0.00	85.65	51.39	79.94	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	610.08	446.96	0.00	0.00	94.61	35.89	45.67	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	318.42	213.86	0.00	0.00	47.52	9.50	14.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	163.14	163.14	0.00	0.00	37.65	12.55	25.10	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	4.09	0.22	6.46	0.43	0.22	0.00	0.00	0.22	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	5.23	1.05	6.79	0.52	0.52	0.00	0.00	0.52	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	7.34	2.67	8.01	0.67	0.00	0.00	0.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	5.43	1.25	2.50	0.83	0.00	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	9.32	5.51	12.55	2.28	0.76	0.38	0.00	0.38	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	14.36	4.79	9.58	3.19	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.12	0.68	4.08	0.68	0.00	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	7.35	3.68	11.03	7.35	0.00	0.00	0.00	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	8.79	2.51	5.86	0.84	0.00	0.00	0.00	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	8.83	2.09	5.58	1.86	1.16	0.00	0.46	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	10.00	5.67	7.03	1.08	1.08	0.00	0.00	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	50.67	10.51	5.68	1.47	2.73	0.00	0.21	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	11.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	14.39	2.48	7.94	0.50	0.00	0.50	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	6.23	3.79	5.68	1.08	0.00	0.00	0.54	0.27	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	19.49	4.99	3.85	1.59	0.68	0.00	0.23	0.00	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	8.98	1.47	5.55	1.31	0.65	0.00	0.00	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	48.48	10.02	3.65	1.64	3.28	0.18	0.36	0.18	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	9.02	6.37	4.77	1.59	1.06	0.53	0.00	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	15.01	4.20	3.60	0.00	0.00	0.00	0.00	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	19.36	15.75	9.52	0.98	1.64	0.00	0.00	0.00	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	7.64	3.42	4.39	0.98	0.49	0.16	0.65	0.16	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	44.10	8.47	6.00	1.76	1.59	0.88	0.35	0.18	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	9.85	3.52	5.63	0.70	0.70	0.00	0.70	0.70	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	10.57	1.84	5.06	0.00	0.46	0.46	0.46	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	8.03	5.14	6.43	0.96	0.96	0.00	0.32	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	11.38	12.42	11.04	1.38	0.69	0.34	0.34	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	10.11	17.70	25.28	2.53	2.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	20.05	3.79	6.46	1.78	1.11	0.22	0.00	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	8.89	1.69	3.39	0.00	0.00	0.00	0.42	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	8.78	2.37	3.80	0.24	0.95	0.00	0.24	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	6.87	3.86	7.30	0.00	0.00	0.00	0.86	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	36.11	27.08	18.06	0.00	0.00	0.00	0.00	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	11.33	4.67	6.00	2.33	0.33	0.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	13.08	3.16	9.02	0.90	1.35	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	6.75	2.38	3.97	0.79	0.40	0.00	1.19	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	5.57	2.79	1.86	0.93	0.00	0.00	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	6.05	1.89	8.70	1.14	0.38	0.00	0.76	0.38	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	5.21	1.96	2.93	0.33	0.65	0.00	0.33	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	14.82	6.10	11.77	2.18	0.87	0.00	0.44	1.31	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	11.76	2.26	6.78	0.45	0.45	0.45	0.00	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.06	4.41	10.58	0.00	0.00	0.00	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	5.98	4.65	5.98	0.66	0.00	0.00	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	8.43	4.96	7.44	0.50	0.99	0.50	0.00	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	4.98	2.68	6.89	0.77	0.77	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	8.77	2.42	12.10	2.12	0.91	0.00	0.00	0.91	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	10.39	2.43	8.40	0.44	0.22	0.00	0.00	0.66	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	6.10	3.39	4.74	2.03	0.68	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	25.55	25.55	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	9.15	4.27	7.32	0.61	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	6.29	0.63	5.35	1.57	0.31	0.00	0.63	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	10.29	5.15	7.87	1.51	1.51	0.30	0.30	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	7.91	2.37	6.33	0.00	0.00	0.79	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	9.07	10.20	14.74	2.27	1.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	5.06	15.17	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	14.78	5.09	8.32	0.87	0.37	0.50	0.75	0.37	0.00
Myoblast, donor2	11322-117D8	6.71	2.69	8.25	0.77	1.34	0.00	0.19	0.19	0.00
Myoblast, donor3	11398-118D3	9.25	4.04	12.95	2.02	0.67	0.17	0.84	0.17	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	9.63	16.20	25.98	2.33	1.31	1.17	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	15.07	10.76	15.68	0.00	2.15	0.31	0.00	0.00	0.31
Natural Killer Cells, donor2	11311-117C6	2.11	2.11	6.33	0.00	0.30	0.00	0.00	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	12.33	7.36	9.20	0.74	0.00	0.18	0.00	0.18	0.00
Neural stem cells, donor1	11275-116H6	5.08	1.09	7.26	1.45	0.00	0.00	0.00	0.00	0.73
Neural stem cells, donor2	11352-117H2	5.78	0.00	11.55	3.85	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	12.52	2.28	5.69	1.14	0.00	1.14	1.14	0.00	0.00
Neurons, donor2	11574-120E8	5.50	1.98	9.03	1.32	0.44	0.66	0.44	0.22	0.00
Neurons, donor3	11655-122E8	8.22	0.82	6.58	3.29	0.00	0.00	0.82	0.00	0.00
Neutrophils, donor1	11233-116C9	47.33	60.32	25.06	0.00	5.57	6.50	0.93	0.00	0.00
Neutrophils, donor2	11314-117C9	26.09	28.99	20.29	0.00	0.00	2.90	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	250.45	335.35	119.11	3.67	27.49	45.81	14.05	0.00	3.67
Nucleus Pulposus Cell, donor1	11252-116F1	23.39	11.52	13.42	1.78	1.66	0.36	1.07	0.59	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	16.61	5.86	13.35	0.98	1.95	0.00	0.65	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	7.82	5.01	9.63	0.40	0.40	0.40	1.00	0.40	0.00
Olfactory epithelial cells, donor1	11933-125I7	6.06	1.38	3.72	0.96	0.00	0.00	0.41	0.28	0.00
Olfactory epithelial cells, donor2	11934-125I8	3.76	1.01	4.05	0.87	0.58	0.00	0.43	0.00	0.00
Olfactory epithelial cells, donor3	11935-125I9	5.22	0.68	3.06	0.34	0.45	0.00	0.11	0.45	0.11
Olfactory epithelial cells, donor4	11936-126A1	6.04	0.39	6.14	0.58	0.10	0.00	0.58	0.29	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	15.65	1.81	20.46	1.81	1.20	0.00	0.00	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	4.89	1.91	7.87	0.64	1.28	0.00	1.91	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	12.57	3.43	16.00	3.43	0.00	0.00	3.43	1.14	1.14
Osteoblast - differentiated, donor3	11425-118G3	11.79	3.10	22.35	3.10	1.24	1.24	1.86	0.62	0.62
Osteoblast, donor1	11277-116H8	2.54	0.39	3.52	0.39	0.00	0.00	0.00	0.20	0.00
Osteoblast, donor2	11354-117H4	4.21	0.70	11.24	0.00	0.70	0.00	0.00	1.40	0.00
Osteoblast, donor3	11426-118G4	3.02	1.42	4.09	1.07	0.18	0.18	0.36	0.00	0.18
Pancreatic stromal cells, donor1	11249-116E7	11.03	3.54	10.11	2.70	0.84	0.34	0.76	0.25	0.34
Pericytes, donor1	11491-119E6	4.45	1.22	2.89	0.22	0.11	0.00	0.00	0.00	0.11
Pericytes, donor2	11571-120E5	3.17	2.04	3.40	0.00	0.68	0.23	0.00	0.23	0.00
Pericytes, donor3	11652-122E5	6.92	2.85	5.29	1.83	0.00	0.00	0.20	0.00	0.00
Perineurial Cells, donor1	11499-119F5	8.02	3.16	12.09	1.47	0.45	0.23	0.00	0.11	0.00
Perineurial Cells, donor2	11579-120F4	56.95	26.87	30.36	3.77	3.68	1.38	2.39	0.64	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	46.85	61.20	13.71	0.64	3.19	2.87	0.00	0.00	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	36.73	32.57	9.30	1.22	1.96	2.94	0.49	0.00	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	32.61	25.24	8.41	0.65	1.81	2.59	0.13	0.26	0.13
Placental Epithelial Cells, donor1	11278-116H9	8.37	2.39	11.72	0.96	0.24	0.00	1.67	0.48	0.00
Placental Epithelial Cells, donor2	11355-117H5	7.76	3.33	22.18	1.11	0.00	0.00	2.22	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	7.26	1.18	19.04	2.16	0.00	0.00	1.77	0.59	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	2.53	0.00	1.58	0.63	0.32	0.00	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	6.57	3.19	8.07	2.06	0.38	0.19	0.75	0.56	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	5.48	1.70	10.96	1.96	0.65	0.00	0.26	0.26	0.00
Preadipocyte - breast, donor2	11328-117E5	4.28	0.68	4.28	0.90	0.00	0.00	0.00	0.45	0.23
Preadipocyte - omental, donor1	11468-119C1	3.94	2.24	8.31	0.75	0.64	0.21	0.75	0.00	0.00
Preadipocyte - omental, donor2	11329-117E6	9.17	3.93	7.42	2.62	0.44	0.00	0.87	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	2.44	1.72	5.30	0.43	0.00	0.00	0.72	0.29	0.00
Preadipocyte - perirenal, donor1	11469-119C2	1.97	2.95	4.92	0.00	0.98	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	3.38	1.23	2.46	1.23	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	27.80	7.44	7.97	2.66	2.83	0.00	0.18	0.53	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	6.30	1.19	6.81	1.70	0.68	0.00	0.17	0.17	0.00
Preadipocyte - visceral, donor1	11280-116I2	23.75	5.68	10.90	2.61	1.58	0.19	0.56	0.47	0.19
Preadipocyte - visceral, donor2	11357-117H7	36.35	7.36	7.82	2.30	1.38	0.00	0.92	0.00	0.92
Preadipocyte - visceral, donor3	11429-118G7	14.73	3.97	4.18	1.88	0.73	0.00	0.52	0.21	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	22.02	8.90	9.96	3.62	0.91	0.30	0.45	0.45	0.60
Prostate Epithelial Cells, donor2	11331-117E8	7.58	2.03	5.28	1.22	0.41	0.00	0.68	0.00	0.27
Prostate Epithelial Cells, donor3	11404-118D9	10.90	4.72	7.16	1.04	0.61	0.12	3.37	0.18	0.43
Prostate Stromal Cells, donor1	11254-116F3	27.22	9.34	10.25	4.56	1.59	0.11	0.68	0.34	0.11
Prostate Stromal Cells, donor2	11332-117E9	11.83	3.05	6.63	1.61	0.54	0.00	0.54	0.18	0.18
Prostate Stromal Cells, donor3	11405-118E1	24.92	6.78	15.33	3.55	0.94	0.00	1.04	0.83	0.94
Renal Cortical Epithelial Cells, donor1	11516-119H4	9.85	4.01	1.46	0.36	1.46	0.00	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	24.33	5.20	12.13	2.22	1.18	0.07	0.62	0.35	0.07
Renal Epithelial Cells, donor1	11517-119H5	2.54	0.00	2.03	0.51	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	12.09	2.13	2.13	0.71	0.71	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	38.11	7.94	22.02	3.81	0.74	0.53	1.27	0.21	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	5.45	6.81	2.72	0.00	0.68	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	7.28	2.56	3.91	0.81	0.40	0.27	0.00	0.27	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	31.53	19.54	5.77	1.11	1.11	0.44	0.00	0.67	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	13.31	10.65	1.33	0.00	0.67	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	2.86	0.88	3.30	0.22	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	7.52	1.88	6.90	0.00	0.63	0.00	0.00	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	1.11	0.55	2.22	0.00	0.28	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	35.97	11.81	10.74	1.88	1.88	0.27	0.00	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	18.55	7.17	5.48	2.53	0.84	0.00	0.42	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	7.91	1.35	6.17	1.35	0.19	0.00	0.19	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	4.15	1.30	9.07	2.07	0.00	0.00	0.00	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	4.55	0.85	5.68	0.28	0.00	0.00	0.57	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	4.12	0.00	2.06	3.09	1.03	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	8.28	2.76	12.04	1.25	0.00	0.00	0.25	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	44.77	38.22	19.64	5.08	3.88	2.67	2.94	1.07	1.74
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	117.04	12.51	19.65	9.83	4.47	0.00	0.00	4.47	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	136.49	26.42	25.32	9.36	3.85	0.00	0.55	2.75	3.30
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	85.27	10.44	20.88	12.76	1.74	0.58	0.00	4.06	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	13.91	4.16	14.30	2.99	0.52	0.39	0.39	1.17	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	15.89	2.88	13.11	5.36	0.40	0.10	0.10	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	19.97	4.57	18.85	6.58	0.22	0.11	0.33	1.67	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	12.65	5.83	17.99	5.21	0.74	0.12	0.37	0.99	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	16.67	3.26	15.85	6.76	0.47	0.00	0.23	1.52	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	20.80	4.39	19.42	7.40	0.46	0.23	0.23	2.08	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	12.46	3.42	11.09	1.64	0.41	0.00	0.00	1.51	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	16.19	1.66	15.73	6.20	0.15	0.00	0.15	1.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	15.95	3.23	16.66	8.24	0.72	0.00	0.00	1.79	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	12.05	4.45	11.62	2.15	0.57	0.00	0.29	2.15	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	16.85	3.00	11.70	6.98	0.32	0.00	0.00	1.07	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	12.17	3.32	15.27	6.86	0.44	0.00	0.00	1.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	11.66	3.44	10.13	1.91	0.19	0.00	0.19	1.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	15.93	2.61	13.79	5.68	0.75	0.09	0.47	1.12	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	21.23	6.39	19.54	6.39	0.75	0.00	0.19	0.75	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	14.47	4.38	10.22	3.85	0.27	0.00	0.40	1.33	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	12.65	2.53	14.21	5.74	0.29	0.00	0.10	0.58	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	16.42	3.44	16.42	5.92	0.57	0.00	0.19	1.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	12.17	2.88	11.00	3.42	0.11	0.21	0.00	1.07	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	12.61	3.64	14.58	4.48	0.28	0.00	0.00	1.40	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	18.63	4.27	16.41	5.30	0.17	0.17	0.17	1.03	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	12.95	3.83	10.21	4.74	0.73	0.00	0.00	0.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	11.04	3.31	11.90	3.56	0.25	0.00	0.00	0.98	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	16.92	3.49	14.37	6.31	0.67	0.13	0.00	1.34	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	13.44	4.01	9.67	1.89	0.94	0.00	0.00	1.65	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	13.29	3.77	12.90	5.36	0.40	0.20	0.20	1.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	17.30	6.31	17.30	5.14	0.47	0.00	0.00	0.47	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	12.23	4.77	12.65	2.07	0.00	0.21	0.41	0.83	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	17.48	3.54	15.04	5.75	0.44	0.22	0.22	0.44	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	16.08	4.80	16.29	5.64	0.63	0.00	0.00	1.67	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	11.17	3.77	10.36	2.83	1.08	0.13	0.40	1.48	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	16.18	4.60	14.65	6.64	0.51	0.34	0.00	1.70	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	19.86	4.82	14.07	5.78	0.39	0.00	0.19	1.54	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	12.04	5.67	16.51	1.38	0.69	0.00	0.17	1.55	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	16.32	5.21	12.89	5.21	0.41	0.27	0.14	1.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	18.22	5.42	15.43	6.40	1.15	0.66	0.16	1.64	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	15.00	2.90	15.85	3.41	0.68	0.00	0.00	1.02	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	18.35	4.59	14.80	5.33	0.44	0.00	0.30	1.63	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	21.06	4.53	18.66	6.40	0.53	0.27	0.00	1.87	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	15.90	4.70	10.92	4.01	0.55	0.28	0.00	0.55	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	14.05	3.33	15.48	3.10	0.95	0.48	0.24	1.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	25.80	5.84	18.54	9.47	0.40	0.60	0.00	2.02	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	13.56	2.92	12.34	2.54	0.47	0.09	0.00	0.66	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	34.24	6.99	21.66	6.99	0.70	0.00	0.00	1.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	34.75	9.37	19.95	10.58	0.30	0.30	0.00	0.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	22.15	5.02	13.71	3.67	0.37	0.24	0.12	1.22	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	112.08	28.82	29.69	18.19	4.51	0.73	0.73	3.06	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	34.07	8.52	25.55	6.08	0.00	0.00	0.00	1.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	16.58	5.12	15.37	3.01	0.90	0.00	0.00	1.81	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	67.86	14.25	21.71	8.82	2.71	0.90	0.45	1.36	4.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	54.22	9.88	22.47	12.28	0.60	0.00	0.60	1.80	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	53.02	13.58	15.70	5.79	2.24	0.71	0.71	1.53	7.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	100.96	15.15	19.21	11.74	2.77	0.85	1.28	0.85	12.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	64.30	13.22	22.24	15.63	3.00	0.00	0.00	3.00	1.80
Schwann Cells, donor1	11498-119F4	2.44	0.19	3.01	0.38	0.38	0.00	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	3.40	0.00	10.21	3.40	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	10.08	3.51	5.70	1.31	0.66	0.22	0.22	0.00	0.22
Sebocyte, donor1	11220-116B5	28.48	3.83	7.67	0.55	0.55	0.00	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	16.54	3.22	5.51	1.84	0.92	0.00	0.00	0.00	0.46
Sebocyte, donor3	11378-118B1	5.36	1.86	5.57	0.62	0.00	0.00	0.41	0.21	0.00
Sertoli Cells, donor1	11255-116F4	16.57	8.28	21.54	3.31	1.66	3.31	0.00	0.00	1.66
Sertoli Cells, donor2	11333-117F1	2.82	0.00	11.30	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	10.29	5.63	7.39	1.14	0.44	0.09	0.18	0.18	0.09
Skeletal Muscle Cells, donor2	11358-117H8	0.00	2.17	5.78	0.00	1.45	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	5.85	1.67	7.52	0.84	0.00	0.84	0.00	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	14.45	5.18	10.05	2.51	1.10	0.16	0.31	0.31	0.16
Skeletal Muscle Cells, donor5	11455-119A6	16.20	5.20	11.59	2.53	0.59	0.15	0.30	0.59	0.15
Skeletal Muscle Cells, donor6	11459-119B1	12.31	2.62	14.62	3.39	0.15	0.00	0.00	0.46	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	35.03	13.48	33.01	5.04	2.65	0.25	1.89	0.50	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	28.97	7.42	17.41	3.00	1.57	0.14	1.28	0.57	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	16.87	5.16	12.90	3.57	0.60	0.30	0.30	1.09	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	10.53	2.78	10.95	2.27	0.42	0.25	1.01	0.25	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	5.07	0.00	5.07	0.00	0.72	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	3.03	0.96	3.85	0.41	0.28	0.00	0.41	0.00	0.00
Skin - palm, donor1	10286-104F7	77.90	26.86	5.37	2.69	2.69	0.00	2.69	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	4.90	1.44	3.75	0.72	0.14	0.00	0.00	0.14	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	21.27	6.54	11.45	2.45	1.64	0.00	0.00	1.64	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	7.40	3.51	5.84	0.65	0.65	0.26	0.39	0.26	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	6.95	3.48	9.04	0.56	1.11	0.00	1.53	0.00	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	6.61	4.92	3.80	0.84	0.84	0.00	0.56	0.00	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	20.51	12.90	15.01	2.11	1.69	0.63	0.63	0.63	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	6.67	1.72	6.67	0.52	0.45	0.07	1.80	0.07	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	1.23	0.31	1.54	0.31	0.31	0.00	0.62	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	2.45	0.67	5.78	0.00	0.22	0.00	0.00	0.44	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	4.70	3.53	7.64	1.76	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	128.40	31.16	4.86	4.20	5.75	0.22	0.88	0.22	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	6.69	0.39	4.33	0.79	0.00	0.00	0.00	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	10.04	3.09	5.41	1.55	0.77	0.00	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	33.02	5.00	27.02	1.00	0.00	0.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	5.32	2.00	7.72	0.80	0.27	0.13	0.27	0.00	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	8.42	2.22	3.99	1.11	0.44	0.00	0.44	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	9.09	2.69	4.87	1.41	0.64	0.13	0.51	0.26	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	26.05	14.98	12.70	0.98	1.30	0.65	0.00	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	16.54	6.20	15.65	1.48	1.48	0.00	0.30	0.89	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	19.79	9.40	19.93	2.70	1.00	0.43	0.57	0.57	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	2.60	0.65	7.65	1.30	0.16	0.16	0.49	0.49	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	41.71	12.48	32.88	7.00	2.74	0.61	2.44	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	10.61	2.02	5.81	0.76	0.51	0.25	0.25	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	30.60	6.12	0.00	0.00	0.00	0.00	0.00	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	9.54	1.91	3.81	1.43	0.48	0.00	0.00	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	16.37	5.75	19.17	2.95	0.88	0.15	0.44	0.29	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	16.79	6.46	20.88	1.29	1.51	0.00	0.43	0.65	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	19.31	7.87	17.74	4.20	1.47	0.42	0.52	0.73	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	4.80	1.39	5.72	0.46	0.31	0.00	0.15	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	7.55	2.16	5.39	0.00	0.00	0.00	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	8.07	1.49	4.78	0.60	0.90	0.00	0.90	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	6.83	2.39	9.22	3.07	0.34	0.00	1.02	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	57.17	15.08	47.59	8.17	3.14	0.79	4.24	0.39	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	2.21	0.81	3.52	0.00	0.20	0.00	0.40	0.10	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	311.75	70.77	9.10	8.65	11.83	0.23	3.41	1.37	1.82
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	3.02	0.00	2.42	0.00	0.60	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	22.78	6.36	18.54	6.09	1.32	0.00	0.00	1.06	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	7.99	4.26	5.46	0.53	0.80	0.13	0.93	0.00	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	30.80	9.02	19.66	3.26	1.25	0.13	1.75	0.50	0.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	12.43	4.06	11.92	0.51	0.25	0.51	1.27	0.76	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	10.86	3.62	9.50	1.66	0.45	0.30	0.60	0.60	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	14.25	6.75	4.50	2.25	0.75	0.00	1.50	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	11.63	0.00	1.29	0.00	0.00	0.00	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	2.79	3.72	4.19	0.47	0.00	0.00	0.47	0.47	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	19.19	2.52	8.08	3.03	2.02	0.00	0.50	1.01	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	61.11	12.85	7.52	4.39	3.76	0.31	1.88	0.63	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	4.72	2.06	4.72	0.88	0.29	0.00	0.88	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	17.08	4.42	19.83	3.92	0.92	0.33	0.25	0.75	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	32.70	9.81	21.49	4.20	1.40	1.40	1.40	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	3.45	1.30	5.47	0.43	0.00	0.00	0.14	0.14	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	8.92	1.78	5.86	0.76	0.51	0.51	0.76	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	3.95	1.50	4.32	0.56	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	10.48	3.07	12.16	1.96	0.56	0.00	0.28	0.42	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	4.86	2.60	7.54	1.51	0.50	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	12.38	0.95	9.05	0.00	0.95	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	2.94	1.96	4.89	1.22	0.49	0.00	0.49	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	2.65	0.22	3.98	0.22	0.22	0.00	0.44	0.00	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	7.31	1.46	7.31	1.76	0.29	0.00	0.29	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	12.05	3.89	16.33	1.75	0.97	0.39	0.97	0.78	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	3.97	0.79	6.88	0.53	0.53	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	12.65	5.58	15.99	2.98	0.74	0.00	0.37	0.74	1.86
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	8.26	2.16	5.75	0.36	0.72	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	2.84	0.28	5.68	0.00	0.00	0.00	0.28	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	5.91	1.18	11.03	1.58	0.39	0.00	0.00	0.79	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	14.98	3.81	15.74	2.03	1.02	0.00	1.52	0.51	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	21.96	3.99	14.77	0.80	0.80	0.40	0.00	0.40	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	7.52	2.93	9.61	1.25	0.42	0.00	0.42	0.84	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	24.29	7.79	12.83	2.29	0.92	0.00	2.29	0.46	0.00
Synoviocyte, donor1	11291-117A4	4.54	1.51	6.40	0.50	0.17	0.00	0.17	0.00	0.00
Synoviocyte, donor2	11368-117I9	20.45	4.86	4.53	1.68	1.17	0.17	2.35	0.34	0.00
Synoviocyte, donor3	11440-118H9	12.96	3.80	8.04	1.56	0.45	0.00	1.12	0.22	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	13.22	4.29	7.15	0.36	1.43	0.36	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	25.77	5.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	9.26	1.39	5.09	1.16	0.46	0.00	0.00	0.46	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	6.16	2.58	5.81	1.22	0.43	0.00	0.14	0.07	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	3.09	0.77	3.48	0.39	0.00	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	5.15	1.15	1.72	0.00	0.00	0.57	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	51.18	39.98	21.53	3.94	4.67	4.43	2.09	0.25	1.23
Urethra, donor2	10319-105A4	66.54	19.78	10.79	0.00	3.60	1.80	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	16.21	1.86	2.92	0.53	0.27	0.00	0.00	0.27	0.00
Urothelial Cells, donor2	11600-120H7	14.02	4.01	2.40	0.40	0.40	0.00	0.40	0.00	0.00
Urothelial Cells, donor3	11681-122H7	8.94	1.83	2.75	0.69	0.69	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	60.18	8.25	6.69	3.57	1.34	0.00	0.00	0.45	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	24.02	55.17	22.24	0.89	4.45	8.90	1.78	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	34.31	51.47	32.88	0.00	5.72	8.58	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	17.80	30.12	13.69	2.05	2.05	4.11	0.68	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	16.53	23.41	17.91	0.00	1.03	2.07	0.69	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	21.50	26.15	22.66	0.58	0.00	3.49	1.16	1.16	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	27.07	67.68	28.11	0.00	8.33	12.49	4.16	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	24.78	47.73	18.36	2.75	5.51	11.93	2.75	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	13.69	40.17	16.43	0.00	1.83	3.65	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Wilms' tumor cell line:HFWT	10597-108E3	25.52	0.88	26.40	5.28	0.88	0.00	7.04	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	34.64	6.70	8.94	10.61	1.96	0.00	0.28	1.12	0.00
achilles tendon, donor2	10292-104G4	113.66	121.93	12.40	6.20	10.33	20.67	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	0.51	0.25	1.27	0.25	0.00	0.00	0.00	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	13.93	10.45	3.95	0.46	0.93	0.46	0.46	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	7.95	4.27	16.26	2.26	0.47	0.24	0.12	0.36	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	11.16	1.90	11.70	4.63	0.27	0.00	0.00	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	17.99	16.02	14.05	1.12	0.84	1.12	0.00	0.56	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	29.40	24.74	14.17	2.96	2.11	2.54	0.00	1.06	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	30.22	21.23	11.98	2.45	0.27	1.09	0.00	0.82	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	16.30	16.74	4.85	1.76	0.44	0.88	0.00	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	45.33	44.92	13.07	4.49	2.45	4.49	0.00	0.41	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	12.81	11.65	3.88	1.16	0.39	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	5.70	8.10	6.81	1.29	0.74	0.55	0.18	0.37	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	54.61	23.40	15.60	11.70	3.90	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	28.35	21.84	10.46	3.25	2.09	1.86	0.00	0.23	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	18.64	23.04	4.14	1.29	2.07	0.52	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	11.69	14.32	2.92	0.29	0.88	1.46	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	14.87	11.62	2.79	1.39	0.93	1.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	35.78	39.07	1.65	2.06	5.76	2.47	0.41	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	17.19	20.57	0.61	1.23	3.07	0.92	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	16.64	25.60	0.00	0.85	2.13	0.85	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	18.50	29.12	1.21	0.91	3.34	0.61	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	18.29	28.88	0.72	0.24	0.72	2.17	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	12.47	7.57	6.68	2.00	0.67	0.67	0.00	0.00	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	54.70	4.00	19.68	7.67	0.67	0.00	1.00	1.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	44.60	14.87	33.45	7.43	1.86	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	23.35	7.16	16.95	3.77	1.13	0.38	0.00	1.51	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	27.04	10.03	10.90	3.05	1.31	0.87	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	59.98	33.74	22.49	3.75	3.75	0.00	0.00	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	95.85	39.33	6.12	4.00	10.60	0.94	0.24	0.71	0.00
adipose tissue, adult, pool1	10010-101C1	98.81	93.07	11.01	2.48	7.45	4.34	2.33	0.00	5.58
adipose, donor1	10184-103D4	0.59	1.76	13.49	1.17	0.00	0.59	0.59	0.00	0.00
adipose, donor2	10185-103D5	1.62	0.00	3.24	0.00	0.41	0.00	0.41	0.00	0.41
adipose, donor3	10186-103D6	2.18	0.82	5.45	0.00	0.00	0.00	0.00	0.00	0.82
adipose, donor4	10187-103D7	5.20	1.73	29.47	0.87	0.00	0.00	0.87	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	0.79	0.16	2.21	0.63	0.00	0.00	0.16	0.47	0.00
adrenal gland, adult, pool1	10081-102A9	14.55	14.55	10.91	0.00	0.00	3.64	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.53	0.53	0.27	0.00	0.27	0.00	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	2.86	0.71	4.29	1.43	0.00	0.00	0.00	0.71	0.36
amniotic membrane cells, donor1	12235-129G3	47.07	14.84	20.63	2.09	3.25	0.23	1.85	0.46	0.00
amniotic membrane cells, donor2	12236-129G4	36.85	5.75	38.54	8.11	1.69	0.68	4.06	1.35	0.68
amniotic membrane cells, donor3	12237-129G5	14.44	1.18	18.85	2.06	1.47	0.00	5.30	0.59	0.59
amygdala - adult, donor10196	10167-103B5	21.34	33.20	4.74	0.00	5.93	5.93	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	22.71	25.55	8.31	1.42	1.62	2.84	1.01	0.61	0.00
amygdala, newborn, donor10223	10360-105E9	22.27	15.17	7.75	1.61	4.20	1.61	2.26	0.97	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	157.51	57.04	20.63	4.84	9.42	1.02	1.02	0.38	0.89
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	158.41	144.73	8.16	2.65	26.47	10.37	2.43	0.22	0.88
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	5.01	1.00	5.01	1.34	0.33	0.00	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	33.15	20.99	12.36	3.53	1.96	2.35	2.16	0.78	0.39
appendix, adult	10189-103D9	65.98	35.32	22.12	6.99	3.88	3.10	3.49	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	14.10	5.16	29.92	3.44	0.34	0.00	1.38	0.69	0.00
artery, adult	10190-103E1	17.66	12.23	8.15	0.00	1.36	0.00	1.36	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	16.80	5.94	23.03	6.52	0.72	0.00	0.72	0.87	0.14
b cell line:RPMI1788	10427-106D4	36.13	12.64	9.67	1.64	2.38	0.45	0.00	0.15	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	1.11	0.28	4.99	0.00	0.00	0.00	0.55	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	35.13	12.60	7.94	4.27	1.69	0.10	0.50	0.20	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	132.06	64.78	8.54	7.53	15.73	1.51	1.84	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	21.81	12.86	1.68	0.00	0.00	1.12	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	44.11	29.77	17.38	3.59	2.61	2.82	2.28	0.22	0.98
blood, adult, pool1	10053-101G8	33.22	48.72	8.86	0.00	2.21	4.43	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	5.14	2.57	10.28	2.57	0.86	0.00	1.71	0.00	0.00
bone marrow, adult	10192-103E3	45.89	31.72	14.85	2.70	3.37	3.37	2.02	0.00	0.00
brain, adult, donor1	10084-102B3	7.18	3.08	3.08	0.00	0.00	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	16.04	15.81	6.90	1.11	1.45	2.00	0.33	0.33	0.00
brain, fetal, pool1	10085-102B4	5.34	0.00	5.34	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	5.62	1.65	3.30	2.97	0.00	0.00	0.00	0.33	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	5.49	0.87	1.75	1.00	0.25	0.00	0.00	0.25	0.00
breast, adult, donor1	10080-102A8	39.14	31.57	10.73	0.63	6.31	1.26	1.89	1.89	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	13.72	5.08	9.40	4.57	1.02	0.00	0.13	0.64	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	26.28	8.66	12.68	2.78	1.24	0.31	0.62	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	9.67	1.84	29.24	3.91	1.15	0.00	0.23	1.15	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	22.03	3.15	12.35	5.81	1.69	0.00	0.24	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	3.29	2.35	2.82	1.41	0.00	0.00	0.47	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	26.58	9.19	14.22	4.16	1.86	0.22	1.31	0.55	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	5.39	0.32	7.29	3.17	0.32	0.00	0.00	0.63	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	11.18	2.93	7.45	4.53	0.80	0.00	0.27	1.06	0.00
caudate nucleus - adult, donor10196	10177-103C6	69.08	36.84	10.36	2.30	8.06	13.82	4.61	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	32.80	27.94	11.38	3.01	3.01	2.84	1.00	0.17	0.00
caudate nucleus, adult, donor10258	10379-105H1	9.93	9.17	6.88	0.00	0.76	0.00	0.76	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	33.33	20.88	13.55	4.03	5.86	3.66	5.49	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	29.13	26.22	8.74	0.00	0.00	5.83	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	16.23	17.93	5.98	0.64	1.49	0.64	0.85	0.00	0.00
cerebellum, adult, pool1	10083-102B2	5.52	3.10	2.07	0.34	0.69	0.00	0.00	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	16.61	10.79	2.49	0.00	2.49	0.00	0.83	0.00	0.00
cerebral meninges, adult	10188-103D8	14.62	9.83	9.08	1.76	0.76	0.00	0.25	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	38.01	35.08	1.46	0.73	5.85	3.65	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	69.30	8.48	6.61	4.17	3.02	0.00	0.58	0.58	0.14
cervical cancer cell line:ME-180	10553-107I4	39.27	18.06	13.42	7.29	2.15	0.17	0.83	0.50	0.00
cervix, adult, pool1	10013-101C4	41.16	20.37	30.66	4.62	2.31	0.84	2.73	0.94	1.05
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	34.56	15.19	19.93	4.88	2.37	0.42	0.98	0.56	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	5.23	2.61	1.31	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	25.10	8.82	6.71	3.60	2.11	0.12	0.12	0.50	0.62
choriocarcinoma cell line:SCH	10785-110H2	10.97	1.36	5.17	2.22	0.25	0.00	0.00	0.62	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	5.22	1.42	4.74	1.19	0.24	0.00	0.00	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	105.99	43.02	9.97	5.13	9.12	3.13	1.99	0.57	0.28
chorionic membrane cells, donor2	12239-129G7	16.80	5.67	10.04	1.99	1.09	0.10	0.99	0.10	0.50
chorionic membrane cells, donor3	12240-129G8	155.50	64.29	5.49	7.69	18.13	2.20	1.65	0.00	3.85
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	19.19	7.07	9.09	1.01	1.01	0.00	2.02	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	25.55	28.81	16.14	2.31	1.92	1.15	0.00	0.19	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	23.65	12.04	12.04	2.32	1.06	0.21	0.42	0.42	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	7.70	2.31	20.54	2.05	0.51	0.00	0.51	0.51	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	10.64	2.66	22.49	3.39	0.48	0.00	0.00	0.73	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	10.79	2.24	20.36	3.46	0.41	0.00	0.20	0.41	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	5.30	0.59	18.85	2.36	0.00	0.00	0.29	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	35.18	19.55	26.84	5.21	1.56	0.52	0.00	1.04	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	14.63	2.51	13.94	3.43	0.69	0.23	0.23	0.91	0.69
clear cell carcinoma cell line:TEN	10636-108I6	36.78	7.29	17.18	7.98	1.74	0.00	0.52	0.69	0.00
colon carcinoma cell line:CACO-2	10513-107D9	45.03	10.98	29.29	6.96	2.01	0.37	6.96	0.55	0.18
colon carcinoma cell line:COLO-320	10420-106C6	4.18	3.42	19.38	2.66	0.38	0.38	0.38	0.76	0.00
colon, adult, donor1	10082-102B1	55.93	24.99	10.71	2.38	1.19	0.00	1.19	1.19	1.19
colon, adult, pool1	10014-101C5	49.59	30.90	18.33	4.23	3.17	2.59	2.82	0.71	1.41
colon, fetal, donor1	10070-101I7	62.42	16.07	15.45	5.56	2.47	1.85	3.71	1.24	1.24
common myeloid progenitor CMP, donor1	12130-128D6	55.00	32.08	41.25	9.17	4.58	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	25.04	0.00	0.00	0.00	0.00	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	7.22	6.37	10.62	0.00	2.12	0.42	1.27	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	7.24	5.89	11.62	0.60	1.21	0.15	0.00	0.00	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	7.33	6.49	13.68	0.85	0.56	0.14	0.00	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	16.69	14.48	7.63	1.22	1.11	0.77	0.66	0.22	0.11
cruciate ligament, donor2	10295-104G7	91.58	55.11	14.59	4.86	8.10	2.43	1.62	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	28.89	23.27	9.63	3.21	0.00	1.61	4.01	0.00	0.00
diencephalon, adult	10193-103E4	6.48	6.24	3.60	0.48	0.24	0.00	0.48	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	0.00	0.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	31.03	8.72	25.13	7.69	1.54	0.00	1.54	0.51	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	12.28	1.20	3.85	1.93	0.48	0.24	0.00	0.00	0.00
ductus deferens, adult	10196-103E7	40.37	16.45	22.92	5.48	5.48	0.00	3.99	1.00	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	57.61	36.01	21.60	5.76	1.44	2.88	2.88	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	70.62	32.37	30.90	2.21	5.15	2.21	2.21	0.00	0.74
dura mater, adult, donor1	10041-101F5	97.78	83.33	11.56	3.06	8.92	4.21	1.32	0.41	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	91.27	27.76	4.44	3.11	4.22	0.67	0.44	0.00	1.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	10.46	1.72	8.60	1.72	0.57	0.00	0.29	0.29	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	19.73	3.70	8.63	3.08	0.62	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	12.71	2.12	12.71	2.12	0.91	0.00	0.61	0.91	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	14.51	5.56	11.11	2.78	0.93	0.00	0.31	0.62	0.00
embryonic pancreas cell line:2C6	10603-108E9	23.64	3.94	13.13	2.63	0.00	0.00	0.00	2.63	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	160.22	45.25	24.13	8.72	12.40	0.67	1.01	1.01	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	13.59	2.90	11.06	4.71	0.54	0.00	0.91	0.18	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	6.91	0.80	8.04	0.48	0.48	0.32	0.32	0.32	0.00
epidermoid carcinoma cell line:A431	10426-106D3	87.70	20.90	11.89	8.78	3.56	0.33	0.78	0.56	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	48.28	12.43	16.94	9.13	0.88	0.22	1.21	0.44	0.22
epididymis, adult	10197-103E8	53.37	19.05	23.86	3.56	4.19	2.09	1.88	0.63	2.09
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	29.80	3.55	10.11	4.44	0.53	0.00	0.18	0.89	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	4.33	0.39	1.97	1.18	0.00	0.00	0.00	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	24.77	9.30	6.42	5.24	1.83	0.13	0.00	1.18	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	33.95	11.02	8.66	7.87	2.46	0.10	0.00	0.49	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	28.90	8.74	6.50	5.38	1.79	0.11	0.11	0.78	0.00
esophagus, adult, pool1	10015-101C6	37.59	23.89	16.78	3.19	2.55	1.49	3.29	0.42	0.96
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	1.25	0.13	0.00	0.00	0.13	0.00	0.00	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	173.85	67.61	9.66	7.24	16.90	2.41	2.41	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	54.71	33.67	2.10	2.10	4.21	4.21	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	38.69	13.39	5.95	0.00	8.93	0.00	2.98	0.00	0.00
eye - muscle superior, donor2	10297-104G9	63.06	26.37	4.59	2.29	5.73	2.29	4.59	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	49.55	37.89	13.12	1.46	2.91	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	18.05	8.64	7.63	2.29	0.51	0.51	0.25	0.00	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	24.75	7.95	13.08	5.26	0.64	0.51	0.13	0.90	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	31.10	5.94	11.63	4.51	1.90	0.00	0.24	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	9.29	9.38	6.76	0.66	0.19	0.19	0.66	0.00	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	767.74	109.59	7.81	18.62	29.12	1.80	3.00	0.60	2.10
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	58.52	12.89	31.18	8.87	1.74	0.73	0.55	0.82	0.18
gall bladder, adult	10198-103E9	38.15	13.76	15.93	2.90	3.86	0.48	2.41	0.48	0.48
gamma delta positive T cells, donor1	11937-126A2	15.57	5.91	33.28	4.29	0.00	0.54	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	10.08	9.34	23.53	0.75	0.37	0.37	0.37	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	45.83	9.50	1.69	2.75	1.69	0.21	0.21	0.00	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	35.98	19.73	28.05	5.80	4.26	0.19	1.35	1.16	0.19
gastric cancer cell line:AZ521	10549-107H9	22.79	4.10	14.92	4.43	0.98	0.00	0.00	0.98	0.00
gastric cancer cell line:GSS	10560-108A2	0.92	0.00	3.66	0.00	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	13.25	5.25	30.61	3.66	1.60	0.00	2.06	1.14	0.23
giant cell carcinoma cell line:LU65	10487-107B1	70.91	19.85	18.36	5.74	3.56	0.00	1.03	0.80	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	15.40	4.06	9.10	2.10	1.12	0.00	0.14	0.14	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	46.39	14.47	10.48	5.24	3.49	0.50	0.75	0.75	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	11.29	3.27	6.12	2.74	0.42	0.00	0.11	0.74	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	9.55	3.23	7.02	2.95	0.70	0.14	0.56	0.42	0.14
glioblastoma cell line:T98G	10485-107A8	24.61	6.73	17.11	5.63	0.33	0.22	0.22	1.21	0.11
glioma cell line:GI-1	10413-106B8	60.33	9.96	9.66	2.93	1.76	0.59	0.59	0.00	0.29
globus pallidus - adult, donor10196	10175-103C4	68.52	56.86	5.10	0.00	9.48	4.37	2.19	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	54.43	58.58	9.76	2.69	3.66	7.32	1.71	0.49	0.73
globus pallidus, adult, donor10258	10367-105F7	13.69	12.32	2.74	0.00	0.00	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	35.71	27.18	9.59	1.07	4.26	3.73	1.60	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	68.52	31.81	19.58	0.00	2.45	2.45	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	41.81	5.23	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	10.56	2.88	6.72	1.28	0.32	0.00	0.00	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	12.86	4.59	43.62	0.92	0.00	0.46	0.00	0.92	0.00
hIPS +CCl2, biol_rep2	14384-156C1	5.03	4.12	37.95	2.29	0.00	0.00	0.00	0.91	0.00
hIPS +CCl2, biol_rep3	14385-156C2	10.31	4.51	27.70	0.64	0.00	0.00	0.00	0.00	0.64
hIPS, biol_rep1	14380-156B6	7.19	4.31	23.00	0.00	1.44	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	8.23	4.80	26.06	0.69	0.69	0.00	1.37	0.69	0.00
hIPS, biol_rep3	14382-156B8	7.72	5.52	11.03	4.41	1.10	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	0.29	0.00	0.29	0.00	0.00	0.00	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	63.98	34.68	21.23	4.48	6.88	3.59	5.08	0.90	0.00
heart - pulmonic valve, adult	10206-103F8	30.59	18.30	9.94	1.05	2.61	0.52	2.09	0.26	0.00
heart - tricuspid valve, adult	10207-103F9	204.00	139.88	18.32	4.16	20.82	9.16	6.66	0.00	2.50
heart, adult, diseased post-infarction, donor1	10050-101G5	19.59	11.43	3.67	2.24	0.82	0.61	0.20	0.00	0.20
heart, adult, diseased, donor1	10051-101G6	21.72	22.57	4.68	0.00	2.13	1.28	1.28	0.43	0.00
heart, adult, pool1	10016-101C7	36.80	32.20	11.73	0.46	2.99	2.53	2.30	0.23	0.23
heart, fetal, pool1	10046-101G1	26.70	23.31	19.92	2.88	1.75	1.54	2.05	0.41	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	5.55	1.23	7.71	0.62	0.00	0.00	0.00	0.62	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	9.51	7.14	7.14	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	26.19	7.62	6.41	2.21	2.87	0.33	0.00	0.44	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	21.24	9.22	5.34	2.06	1.58	0.24	0.12	0.36	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	22.23	10.21	7.78	2.22	2.83	0.00	0.30	0.30	0.00
hepatoma cell line:Li-7	10484-107A7	22.58	9.01	8.90	3.11	1.45	0.11	0.00	0.11	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	12.46	8.54	3.52	0.30	0.90	0.20	0.00	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	42.58	32.18	2.84	0.95	12.30	7.57	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	26.33	29.59	8.16	1.22	2.86	1.84	1.22	0.00	0.00
hippocampus, adult, donor10258	10374-105G5	7.97	7.47	5.48	0.50	1.99	0.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	16.92	9.52	5.99	0.00	3.17	1.06	1.41	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	14.04	4.27	79.96	9.77	0.61	0.61	4.88	1.22	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	11.39	2.36	50.86	3.93	0.20	0.00	1.57	0.79	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	12.95	3.05	55.35	4.32	0.76	0.00	2.79	1.02	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	1.13	0.00	5.64	0.00	0.00	0.00	0.00	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	2.32	0.52	3.87	1.29	0.26	0.00	0.00	0.00	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	1.90	0.00	7.97	1.14	0.76	0.00	0.00	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	2.63	1.46	4.38	1.75	0.58	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	4.09	2.59	5.17	0.43	0.22	0.00	0.22	0.00	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	7.92	2.09	3.34	1.67	0.00	0.00	0.42	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	7.58	2.37	6.39	0.71	0.47	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	4.34	1.13	5.63	0.96	0.16	0.00	0.64	0.48	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	2.02	0.67	9.43	4.04	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	7.82	1.10	27.38	1.72	0.31	0.00	0.47	0.31	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	11.30	1.97	25.06	1.97	0.49	0.00	0.00	0.49	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	9.60	2.62	41.89	3.49	0.00	0.00	0.00	1.75	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	2.48	1.15	4.39	0.38	0.00	0.00	0.00	0.38	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	3.05	1.31	7.85	0.44	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	1.50	0.50	4.50	2.00	0.00	0.00	0.00	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	1.32	0.75	3.96	0.57	0.00	0.19	0.00	0.00	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	0.91	0.45	3.18	0.45	0.45	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	1.88	1.25	4.70	0.00	0.63	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	2.12	1.96	4.74	0.65	0.16	0.00	0.33	0.33	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	2.03	1.45	3.77	0.58	0.58	0.00	0.29	0.29	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	2.69	1.20	5.98	0.00	0.00	0.00	0.30	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	12.38	1.48	30.85	3.14	0.00	0.00	0.74	0.55	0.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	8.84	1.71	31.38	2.00	0.57	0.00	0.57	0.29	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	13.07	1.22	61.66	3.67	0.00	0.00	1.63	0.82	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	4.93	0.00	10.21	2.11	0.00	0.00	0.00	0.70	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	5.70	1.27	10.77	0.63	0.32	0.00	0.00	0.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	5.45	0.61	10.59	1.51	0.30	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	4.65	2.07	5.69	0.00	0.00	0.00	0.00	1.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	1.99	2.66	6.64	0.00	1.33	0.00	0.00	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	5.64	1.80	6.67	0.51	0.26	0.00	0.26	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	5.62	1.28	6.90	1.02	0.51	0.26	0.51	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	7.57	1.51	6.06	0.00	0.76	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	8.74	1.34	11.76	2.02	1.01	0.34	0.00	0.00	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	7.00	1.45	31.88	2.42	0.48	0.00	0.97	0.97	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	9.36	1.78	32.53	2.23	0.00	0.00	0.45	1.34	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	10.24	1.95	42.44	2.44	0.98	0.00	0.00	0.98	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	2.75	1.53	7.64	0.61	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	9.76	3.25	16.27	0.00	0.00	0.00	0.00	0.00	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	2.98	1.65	7.94	1.32	0.66	0.00	0.00	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	1.09	2.19	8.21	0.00	0.00	0.00	0.00	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	5.79	2.17	7.60	0.36	0.72	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	4.98	1.42	7.47	0.71	0.71	0.00	0.00	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	2.39	2.39	9.55	1.19	0.00	0.00	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	3.66	2.03	9.48	1.22	0.00	0.00	0.41	0.27	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	4.58	0.81	7.54	0.54	0.00	0.00	0.27	0.27	0.27
immature langerhans cells, donor1	11904-125F5	46.73	27.36	4.12	0.00	2.66	1.21	0.00	0.24	0.00
immature langerhans cells, donor2	11905-125F6	24.56	8.71	6.34	1.58	0.79	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	9.27	7.10	8.61	0.95	0.85	0.19	0.38	0.00	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	4.23	2.28	1.63	0.65	0.33	0.00	0.00	0.33	0.00
kidney, adult, pool1	10017-101C8	59.38	29.54	25.73	5.81	5.91	2.30	2.70	0.50	0.80
kidney, fetal, pool1	10045-101F9	35.65	22.14	31.62	4.67	2.69	0.78	1.70	0.57	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	82.51	12.21	10.37	5.25	1.42	0.28	0.57	0.43	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	2.90	1.80	4.56	0.55	0.28	0.00	0.28	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	146.25	23.30	62.57	34.13	5.32	0.73	10.09	1.47	0.37
left atrium, adult, donor1	10079-102A7	36.51	16.35	8.72	2.18	4.90	3.81	0.54	0.54	0.00
left ventricle, adult, donor1	10078-102A6	27.81	13.65	1.01	1.01	2.02	1.01	0.51	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	0.27	0.00	0.27	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	2.51	1.44	2.51	0.36	0.00	0.00	0.00	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	1.63	2.17	2.17	0.00	0.00	0.00	0.54	0.00	0.00
leiomyoma cell line:15425	10571-108B4	3.16	0.24	5.58	0.97	0.24	0.24	0.24	0.49	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	6.35	12.70	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	27.18	6.27	10.46	5.23	0.00	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	131.04	58.91	15.47	3.78	7.91	1.89	0.71	0.59	0.47
liposarcoma cell line:KMLS-1	10782-110G8	3.44	1.25	5.78	0.78	0.16	0.16	0.00	0.47	0.16
liposarcoma cell line:SW 872	10726-110A6	35.58	15.96	11.09	4.26	3.41	0.61	0.73	0.37	0.12
liver, adult, pool1	10018-101C9	46.51	37.76	9.72	3.89	5.67	4.86	3.57	0.16	2.59
liver, fetal, pool1	10086-102B5	15.05	11.29	4.70	0.00	1.88	0.00	0.00	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	60.81	32.66	6.85	1.02	8.75	5.69	1.17	0.00	0.00
locus coeruleus, adult, donor10252	10165-103B3	39.12	42.82	7.75	1.85	4.80	4.98	2.03	0.18	0.55
locus coeruleus, adult, donor10258	10375-105G6	14.67	12.13	3.95	0.28	1.97	0.28	0.85	0.56	0.00
locus coeruleus, newborn, donor10223	10362-105F2	54.68	41.22	12.62	1.26	6.31	6.31	5.05	0.00	0.42
lung adenocarcinoma cell line:A549	10499-107C4	13.29	3.32	12.87	2.21	1.52	0.00	0.14	0.42	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	23.44	7.58	13.79	4.14	2.07	0.00	0.00	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	92.27	12.92	29.66	12.00	3.43	0.26	0.66	0.79	0.13
lung, adult, pool1	10019-101D1	78.08	54.22	14.06	4.84	5.32	4.37	1.89	0.47	2.36
lung, fetal, donor1	10068-101I5	98.75	93.04	47.38	6.56	11.99	11.70	5.99	0.86	0.57
lung, right lower lobe, adult, donor1	10075-102A3	74.69	54.07	8.71	5.04	6.42	5.96	0.92	0.92	0.92
lymph node, adult, donor1	10077-102A5	47.34	44.50	15.15	0.47	1.89	9.47	0.95	0.00	2.37
lymphangiectasia cell line:DS-1	10727-110A7	3.29	3.07	2.41	0.22	0.00	0.22	0.00	0.00	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	7.40	4.38	9.96	0.30	0.15	0.60	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	361.04	56.92	32.28	21.24	12.74	0.85	4.25	0.85	0.00
mature adipocyte, donor1	12231-129F8	19.09	12.43	5.77	0.44	3.55	1.33	2.22	0.00	0.44
mature adipocyte, donor2	12232-129F9	15.77	9.55	4.57	0.21	0.83	1.25	0.21	0.00	0.42
mature adipocyte, donor3	12233-129G1	23.94	18.25	7.11	1.90	2.61	2.84	1.19	0.00	0.00
mature adipocyte, donor4	12234-129G2	25.80	16.85	5.00	0.53	3.42	3.42	1.05	0.00	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	7.39	2.62	20.01	2.38	0.48	0.71	1.67	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	22.56	14.66	6.77	1.13	1.13	2.26	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	27.03	28.51	12.87	2.02	6.44	2.39	1.29	0.18	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	4.45	5.72	5.08	0.64	0.32	0.00	0.00	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	19.19	24.31	8.53	0.00	1.71	2.56	2.99	0.00	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	27.84	19.24	4.73	1.01	3.04	2.70	0.51	0.51	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	29.92	28.23	8.49	1.91	2.97	2.12	0.64	1.27	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	5.78	15.41	1.93	0.00	3.85	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	28.71	28.71	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	15.43	11.84	6.10	1.08	1.79	1.79	1.44	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	48.67	48.02	7.79	1.95	4.54	5.19	0.65	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	36.84	44.12	9.91	1.70	4.64	3.72	1.24	0.31	0.31
medulla oblongata, adult, pool1	10038-101F2	27.02	27.10	9.22	1.71	2.53	1.63	1.47	0.33	0.08
medulla oblongata, newborn, donor10223	10361-105F1	41.31	23.61	9.72	1.39	4.51	3.12	2.78	0.35	0.35
medulloblastoma cell line:D283 Med	10838-111E1	2.44	0.44	7.75	1.11	0.22	0.00	0.22	0.44	0.22
medulloblastoma cell line:ONS-76	10759-110E3	12.23	2.81	6.73	3.79	0.86	0.12	0.12	0.61	0.00
melanoma cell line:COLO 679	10514-107E1	33.64	12.51	29.32	6.04	1.87	0.29	2.44	0.43	0.43
melanoma cell line:G-361	10465-106H6	73.84	32.03	25.52	4.89	7.06	0.81	0.81	0.27	2.17
meningioma cell line:HKBMM	10691-109F7	229.93	25.15	3.62	4.34	5.07	0.00	0.72	0.00	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	9.69	3.52	5.29	6.17	0.88	0.88	0.00	4.41	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	4.15	1.04	6.74	2.33	0.00	0.00	0.00	1.30	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	6.14	1.69	7.21	1.38	0.46	0.00	0.31	0.31	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	6.91	3.09	8.18	0.55	0.36	0.00	0.55	0.18	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	3.31	1.66	5.80	0.00	0.00	0.00	0.41	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	4.50	3.23	6.18	0.56	0.14	0.00	0.28	0.14	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	6.35	2.50	9.05	0.58	0.39	0.00	0.39	0.00	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	90.23	17.35	10.41	4.86	6.25	0.00	0.69	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	9.44	1.54	5.66	0.69	0.51	0.17	0.34	0.17	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	7.59	2.76	7.36	0.81	0.23	0.00	1.04	0.23	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	10.21	2.92	9.02	1.86	0.27	0.00	0.27	0.53	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	13.50	4.05	9.45	3.11	0.41	0.00	0.14	0.27	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	8.39	2.28	6.83	1.28	0.28	0.14	0.14	0.28	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	25.36	2.96	8.23	1.65	0.99	0.00	0.33	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	7.75	2.63	8.99	0.42	0.14	0.14	0.69	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	35.96	7.33	5.93	2.44	3.84	0.00	0.00	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	7.55	1.84	7.15	0.82	0.41	0.00	0.00	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	4.67	1.80	5.75	1.08	0.72	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	7.86	1.45	7.97	0.62	0.21	0.10	0.00	0.21	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	7.98	1.60	4.10	1.14	0.46	0.23	0.23	0.00	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	16.36	2.94	10.07	1.68	0.84	0.00	0.42	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	5.38	2.69	8.52	1.20	0.15	0.15	0.30	0.30	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	7.79	3.59	9.10	0.70	0.96	0.18	0.18	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	7.73	4.05	9.20	1.10	0.37	0.00	0.00	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	5.72	0.57	2.58	0.29	0.00	0.29	0.00	0.29	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	21.89	7.16	13.89	2.95	0.84	0.00	0.42	1.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	4.57	1.37	4.11	1.37	0.91	0.00	0.46	0.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	7.16	2.30	7.42	0.77	0.00	0.00	0.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	6.28	0.79	6.81	0.52	0.52	0.00	0.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	4.31	0.62	6.78	0.62	0.00	0.00	0.62	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	4.71	1.41	4.24	0.94	0.24	0.00	0.47	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	6.77	1.02	6.43	0.68	0.34	0.00	0.68	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	6.29	1.96	7.07	0.00	0.00	0.00	1.57	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	7.41	1.39	4.63	0.46	0.00	0.00	0.93	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	6.63	2.02	7.79	0.58	0.29	0.00	1.15	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	8.25	1.78	8.03	0.89	0.00	0.00	0.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	6.49	2.16	6.01	0.96	0.00	0.24	0.48	0.96	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	9.53	4.40	10.27	1.47	0.73	0.00	0.73	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	3.02	1.01	4.36	1.01	0.34	0.00	0.67	1.01	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	5.73	1.64	3.28	2.05	0.41	0.00	0.82	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	6.01	1.29	4.73	2.15	0.43	0.00	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	0.00	0.00	5.47	2.73	2.73	0.00	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	0.00	10.33	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	5.85	1.95	5.85	0.32	0.00	0.32	0.32	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	5.82	1.45	4.36	1.45	0.00	0.00	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	4.80	1.07	8.53	0.00	0.00	0.00	1.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	4.09	0.00	8.18	1.64	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	6.22	1.94	4.28	0.39	0.00	0.00	0.78	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	6.30	2.10	2.10	0.00	0.00	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	1.99	1.99	4.97	0.00	0.00	0.00	1.99	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	0.00	4.77	0.00	0.00	0.00	4.77	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	7.12	2.96	5.34	0.59	0.00	0.00	1.19	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	8.53	1.22	6.09	1.22	0.00	0.00	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	4.43	3.17	5.07	1.27	0.00	0.00	0.63	1.27	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	4.83	2.07	4.83	0.34	0.00	0.00	2.07	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	15.04	4.30	10.75	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	0.00	23.95	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	0.00	3.44	3.44	0.00	0.00	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	2.04	2.04	5.70	0.41	0.00	0.00	0.81	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	6.36	0.79	4.77	0.79	0.00	0.00	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	2.36	0.00	3.54	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	2.49	0.00	3.43	0.31	0.00	0.00	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	0.00	0.00	8.02	1.34	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	2.37	1.18	5.91	0.00	0.00	0.00	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	0.00	0.00	5.14	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	2.75	0.69	4.13	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	0.99	0.49	2.97	0.00	0.49	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	0.00	0.00	0.00	0.00	0.00	0.00	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	1.91	0.64	2.54	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	0.81	0.00	1.61	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	0.00	2.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	2.53	0.00	1.27	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	4.25	2.43	1.21	0.00	0.00	0.00	1.82	0.00	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	4.94	3.29	3.29	2.47	0.82	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	1.79	0.40	2.98	0.40	0.20	0.00	0.40	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	0.97	0.00	1.30	0.00	0.00	0.00	0.00	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	1.02	0.00	2.04	2.04	1.02	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	34.04	1.55	13.15	2.32	0.77	0.00	0.00	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	55.75	3.54	6.61	3.31	1.65	0.00	0.00	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	249.98	88.73	29.19	16.22	17.84	4.40	5.10	1.39	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	128.21	17.09	0.00	4.27	8.55	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	202.01	41.72	8.43	9.04	8.63	0.31	0.51	0.41	0.92
mesothelioma cell line:Mero-25	10850-111F4	96.23	27.69	6.58	2.50	5.90	1.13	0.23	0.23	0.68
mesothelioma cell line:Mero-41	10851-111F5	10.02	1.22	8.56	1.96	0.73	0.00	0.00	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	6.86	1.99	5.31	1.11	0.22	0.00	0.44	0.66	0.22
mesothelioma cell line:Mero-82	10853-111F7	340.33	78.84	7.36	3.42	19.97	1.05	1.58	0.00	1.84
mesothelioma cell line:Mero-83	10854-111F8	5.28	1.36	4.26	1.36	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-84	10855-111F9	5.81	1.77	3.29	1.01	0.00	0.00	0.00	0.51	0.00
mesothelioma cell line:Mero-95	10856-111G1	11.59	5.59	6.83	3.31	1.04	0.41	0.21	0.21	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	6.29	3.31	4.64	0.66	0.33	0.17	0.00	0.66	0.00
mesothelioma cell line:NCI-H226	10846-111E9	11.76	2.35	3.98	1.63	0.90	0.00	0.00	0.36	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	112.06	21.35	5.81	10.08	4.95	0.51	0.68	1.71	0.51
mesothelioma cell line:NCI-H28	10845-111E8	9.42	1.27	8.14	2.54	0.51	0.00	0.51	0.76	0.25
mesothelioma cell line:No36	10857-111G2	14.35	4.24	4.57	3.26	1.30	0.33	0.00	1.96	0.00
mesothelioma cell line:ONE58	10858-111G3	118.14	26.82	8.13	5.15	6.23	0.81	1.08	0.81	1.08
migratory langerhans cells, donor1	11901-125F2	1.34	1.54	4.22	0.00	0.00	0.00	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	1.22	0.73	3.30	0.12	0.12	0.12	0.00	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	4.49	1.79	6.46	0.18	0.90	0.36	0.00	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	100.88	14.04	6.86	4.57	3.92	0.00	0.65	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	47.90	10.17	16.32	5.09	3.18	0.00	0.64	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	88.00	16.36	26.95	17.97	2.76	0.23	1.84	1.15	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	5.90	3.81	3.04	0.76	0.19	0.00	0.00	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	47.68	33.45	7.76	5.36	3.33	1.29	0.00	1.11	0.18
myeloma cell line:PCM6	10474-106I6	10.67	11.46	1.38	0.20	1.58	0.40	0.20	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	22.83	5.07	8.12	3.55	0.51	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	19.22	10.79	9.02	1.96	0.98	0.00	0.20	0.78	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	12.93	4.79	8.80	1.23	0.56	0.22	2.79	0.11	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	12.65	4.78	10.22	1.40	1.40	0.07	1.54	0.22	0.07
nasal epithelial cells, donor2	12227-129F4	9.38	2.21	9.38	1.10	1.10	0.00	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	5.29	2.76	19.79	2.07	0.23	0.23	0.46	0.92	0.00
neuroblastoma cell line:NB-1	10539-107G8	7.67	0.37	14.97	3.93	0.37	0.00	0.00	0.75	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	1.69	2.32	7.80	1.69	0.42	0.00	0.00	0.63	0.00
neuroblastoma cell line:NH-12	10555-107I6	2.98	0.00	5.03	0.19	0.00	0.00	0.00	0.37	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	3.32	0.00	3.32	1.19	0.24	0.00	0.00	0.47	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	1.90	0.48	3.80	1.74	0.00	0.00	0.00	0.63	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	2.21	1.01	4.83	2.01	0.20	0.00	0.00	0.40	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	6.36	0.00	5.09	4.45	0.64	0.00	0.00	1.27	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	2.66	1.60	4.52	1.60	0.53	0.00	0.53	0.27	0.00
neutrophil PMN, donor1	12133-128D9	104.12	59.50	74.37	0.00	0.00	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	106.25	159.37	106.25	0.00	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	85.24	151.53	85.24	0.00	9.47	94.71	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	2.88	1.01	3.38	0.68	0.17	0.00	0.00	0.17	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	4.00	0.80	8.01	0.00	0.80	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	9.62	3.21	10.26	0.96	0.32	0.32	0.96	0.32	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	98.01	26.80	9.99	4.47	5.78	0.26	0.79	0.26	0.53
nucleus accumbens, adult, pool1	10037-101F1	12.75	10.22	8.16	1.22	1.22	0.56	1.03	0.37	0.19
occipital cortex - adult, donor10196	10172-103C1	32.97	30.91	8.24	0.00	0.00	4.12	8.24	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	41.60	49.11	15.30	2.42	6.71	3.76	2.15	0.00	0.27
occipital cortex, newborn, donor10223	10355-105E4	14.56	10.55	6.55	0.36	2.55	0.73	1.09	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	6.56	5.25	3.15	0.79	1.57	0.00	0.00	0.26	0.00
occipital lobe, fetal, donor1	10073-102A1	2.15	2.15	2.57	0.43	0.00	0.00	0.00	0.86	0.43
occipital pole, adult, pool1	10036-101E9	7.17	4.57	4.57	0.32	0.55	0.32	0.47	0.08	0.00
olfactory region, adult	10195-103E6	9.17	6.11	3.25	1.34	0.19	0.76	0.57	0.57	0.19
optic nerve, donor1	10277-104E7	36.02	22.01	4.00	6.00	6.00	2.00	2.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	24.38	10.37	11.85	3.30	1.48	0.46	0.11	0.11	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	35.86	6.73	45.75	12.78	1.51	0.14	1.37	1.37	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	116.16	26.08	7.11	5.42	3.05	0.34	0.85	0.34	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	24.95	7.16	10.16	3.00	1.62	0.35	0.12	0.23	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	5.00	2.06	4.70	0.59	0.29	0.29	0.29	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	23.36	7.47	20.56	4.67	0.93	0.00	0.93	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	3.61	1.06	4.67	1.06	0.00	0.00	0.00	0.64	0.00
ovary, adult, pool1	10020-101D2	63.59	33.98	32.15	8.21	5.77	1.48	8.21	0.87	1.92
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	11.18	2.75	4.40	0.73	0.55	0.18	0.00	0.37	0.18
pancreas, adult, donor1	10049-101G4	40.45	14.11	14.11	2.82	4.70	0.94	2.82	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	13.14	2.24	6.71	2.80	0.28	0.00	0.28	0.56	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	22.15	14.31	5.11	3.07	0.85	0.51	0.34	1.02	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	158.30	31.63	29.14	12.25	5.96	0.66	1.32	0.83	0.33
paracentral gyrus, adult, pool1	10035-101E8	9.24	7.32	5.77	0.27	1.01	0.37	0.37	0.00	0.00
parietal cortex, adult, donor10258	10373-105G4	5.87	10.28	8.07	0.73	2.20	0.00	0.00	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	25.39	15.05	5.64	0.94	2.82	8.46	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	26.22	28.50	7.98	1.71	4.28	3.14	1.14	0.29	0.00
parietal lobe, adult, pool1	10034-101E7	10.31	7.05	4.58	0.62	0.70	0.44	0.26	0.18	0.00
parietal lobe, fetal, donor1	10072-101I9	0.97	0.97	1.94	0.00	0.00	0.00	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	17.95	19.07	6.73	1.50	3.74	1.87	1.12	0.00	0.00
parotid gland, adult	10199-103F1	17.27	2.47	3.70	0.62	0.62	0.00	2.47	0.62	0.00
penis, adult	10200-103F2	30.08	21.48	11.28	3.22	1.61	0.54	2.69	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	0.00	0.00	0.19	0.00	0.00	0.00	0.00	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	121.22	37.30	11.95	11.51	5.54	1.02	0.73	0.29	1.31
pineal gland - adult, donor10196	10179-103C8	33.54	20.64	7.74	0.65	5.81	1.29	0.65	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	27.24	42.05	10.07	2.37	1.78	1.18	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	10.66	6.90	5.02	0.63	1.25	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	42.50	35.41	9.11	2.02	4.05	1.01	1.01	1.01	2.02
pituitary gland, adult, donor10252	10162-103A9	46.38	53.68	37.00	4.69	4.17	3.65	0.52	0.00	1.56
pituitary gland, adult, donor10258	10378-105G9	26.39	8.51	19.58	1.70	2.55	0.00	0.00	0.00	0.85
placenta, adult, pool1	10021-101D3	40.31	23.54	11.29	3.12	3.01	0.97	0.86	0.54	0.43
plasma cell leukemia cell line:ARH-77	10840-111E3	94.16	37.08	24.23	3.44	5.56	1.99	0.40	0.13	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	43.89	13.07	21.32	6.07	2.18	0.16	1.87	0.62	0.31
pons, adult, pool1	10033-101E6	14.12	14.29	3.53	0.52	1.29	1.46	0.43	0.17	0.00
postcentral gyrus, adult, pool1	10032-101E5	6.19	6.02	5.06	0.61	0.17	0.26	0.70	0.17	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	23.01	23.01	4.18	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	38.56	11.02	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	11.74	0.00	0.00	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	19.52	5.54	9.18	5.10	1.31	0.58	0.00	0.44	0.29
prostate cancer cell line:PC-3	10439-106E7	34.85	8.35	11.62	4.90	2.18	0.54	0.36	0.36	0.18
prostate, adult, pool1	10022-101D4	42.53	23.85	25.85	4.72	2.45	1.18	2.36	1.00	0.73
putamen, adult, donor10196	10176-103C5	33.05	26.44	7.79	2.83	5.19	5.19	1.89	0.47	0.00
putamen, adult, donor10252	10152-102I8	33.33	21.57	9.80	0.00	9.80	5.88	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	6.56	8.74	6.56	0.00	1.09	1.09	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	8.21	5.56	3.87	0.48	0.48	0.48	0.48	0.24	0.00
putamen, newborn, donor10223	10365-105F5	59.22	48.73	32.24	2.25	9.75	6.75	5.25	0.00	3.00
rectal cancer cell line:TT1TKB	10469-106I1	116.66	12.80	5.82	8.15	1.45	0.29	0.87	0.29	0.00
rectum, fetal, donor1	10067-101I4	69.55	25.04	29.21	11.13	4.17	1.39	1.39	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	27.56	6.78	11.02	4.45	1.70	0.42	0.85	0.42	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	46.39	0.83	7.46	4.14	0.83	0.00	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	29.82	15.71	15.21	2.29	1.89	0.30	1.19	0.10	0.40
retinoblastoma cell line:Y79	10475-106I7	0.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	6.76	1.97	7.13	1.72	0.74	0.12	0.00	0.74	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	9.84	2.53	23.06	5.91	0.28	0.00	0.28	0.84	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	28.80	4.55	28.04	3.03	2.27	0.00	0.76	0.76	0.00
salivary acinar cells, donor1	11771-123I7	13.27	3.40	11.49	2.75	0.81	0.16	0.65	0.49	0.32
salivary acinar cells, donor2	11772-123I8	7.57	3.17	11.43	2.48	0.55	0.41	1.79	0.14	0.14
salivary acinar cells, donor3	11773-123I9	14.57	5.96	13.24	0.66	0.00	0.00	2.65	0.00	0.00
salivary gland, adult, pool1	10093-102C3	14.30	7.44	9.72	1.14	0.00	1.72	1.72	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	16.69	6.15	9.11	2.45	0.84	0.08	0.34	0.25	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	12.81	5.76	8.58	2.70	1.18	0.12	0.12	0.47	0.12
seminal vesicle, adult	10201-103F3	77.24	26.45	25.40	6.88	6.35	0.00	4.23	0.00	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	22.59	6.07	17.49	2.67	1.94	0.24	0.49	0.49	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	15.60	6.54	8.30	1.01	1.01	0.00	0.75	0.50	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	13.05	8.03	13.05	3.01	0.00	0.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	10.48	4.16	6.31	0.67	0.81	0.00	0.13	0.27	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	53.38	20.56	4.09	4.97	3.54	0.33	0.88	0.33	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	46.58	20.00	4.64	3.87	2.71	0.39	0.26	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	25.54	13.48	0.71	0.00	0.71	0.00	0.71	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	31.42	23.39	4.68	1.08	2.04	1.08	0.96	0.00	1.08
skeletal muscle, fetal, donor1	10066-101I3	5.03	2.01	6.03	0.00	0.00	0.00	0.00	1.01	0.00
skin, adult, donor1	10074-102A2	20.36	0.00	0.00	0.00	0.00	0.00	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	24.62	10.73	11.36	3.79	0.63	0.00	1.89	0.63	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	12.01	6.67	9.34	4.67	0.00	0.00	0.33	1.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	2.52	0.32	7.88	0.32	0.00	0.32	0.00	1.26	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	0.39	0.00	1.16	0.19	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	3.46	0.99	6.59	1.32	0.00	0.00	0.00	0.49	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	1.13	0.48	14.96	0.64	0.00	0.00	0.00	0.16	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	137.29	65.38	4.58	7.19	11.55	1.09	1.09	0.65	0.00
small intestine, adult, pool1	10024-101D6	57.69	38.82	15.29	1.55	5.26	2.15	3.22	0.12	1.19
small intestine, fetal, donor1	10064-101I1	72.97	27.52	24.82	5.16	7.37	2.46	1.72	0.49	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	26.67	12.82	12.31	4.62	1.03	0.51	2.05	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	28.43	17.57	12.15	1.03	2.07	0.78	3.10	0.52	0.00
somatostatinoma cell line:QGP-1	10781-110G7	2.95	1.34	4.82	1.61	0.00	0.00	0.27	0.00	0.27
spinal cord - adult, donor10196	10181-103D1	85.11	57.12	6.88	2.52	9.86	8.49	1.38	0.23	0.00
spinal cord, adult, donor10252	10159-103A6	44.16	68.60	14.19	2.76	4.34	3.94	2.37	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	8.99	18.68	6.23	1.38	0.69	0.69	0.00	1.38	0.00
spinal cord, fetal, donor1	10056-101H2	19.51	9.15	19.51	3.05	1.22	0.00	1.22	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	50.97	45.46	19.75	5.05	2.76	1.38	2.30	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	7.02	1.19	6.57	2.69	0.30	0.15	0.00	0.15	0.00
spleen, adult, pool1	10025-101D7	66.19	69.49	26.21	3.41	4.07	6.61	1.43	0.00	0.99
spleen, fetal, pool1	10044-101F8	50.45	54.51	31.15	4.29	4.37	5.16	2.22	0.32	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	15.42	7.97	5.07	0.41	1.04	0.31	0.10	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	131.77	20.13	14.05	9.68	5.13	0.00	1.71	0.38	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	24.81	6.64	7.34	3.49	1.40	0.35	0.35	0.70	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	208.76	30.10	24.24	12.12	9.38	0.78	2.35	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	20.82	17.00	21.39	3.38	1.46	0.68	1.58	0.56	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	25.38	4.23	14.38	5.08	0.42	0.00	0.00	1.27	0.00
stomach, fetal, donor1	10062-101H8	75.83	29.90	20.29	9.61	1.07	1.07	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	36.46	17.09	8.55	3.42	0.57	1.14	4.56	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	54.27	108.55	54.27	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	31.78	41.33	6.44	1.45	3.95	3.95	1.66	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	10.86	9.83	2.07	0.00	2.07	2.07	0.00	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	40.27	28.26	4.95	0.00	7.07	0.71	0.00	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	2.98	0.92	7.80	2.75	0.00	0.23	0.46	1.38	0.00
temporal lobe, adult, pool1	10031-101E4	6.36	3.48	5.34	0.25	0.34	0.25	0.17	0.08	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	2.85	2.14	0.71	0.71	0.00	0.00	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	3.52	2.64	4.40	0.00	0.00	0.00	0.00	0.00	0.00
tenocyte, donor1	11763-123H8	40.50	6.28	5.93	1.40	1.40	0.35	1.05	1.05	0.00
tenocyte, donor2	11765-123I1	29.76	12.21	14.12	3.43	2.67	0.00	0.76	0.76	0.38
tenocyte, donor3	11768-123I4	5.56	1.11	8.53	0.37	0.37	0.00	1.48	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	13.43	2.55	32.63	3.57	0.00	0.51	0.34	1.02	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	13.87	2.93	55.80	9.40	1.23	0.15	3.85	1.70	0.92
teratocarcinoma cell line:PA-1	10807-111A6	4.96	1.55	18.44	2.17	0.15	0.00	0.31	0.31	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	20.69	5.33	45.95	4.82	0.76	0.13	0.51	0.89	0.51
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	13.99	4.54	39.33	1.51	0.38	0.38	1.51	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	18.87	1.09	64.56	3.38	1.09	0.11	2.84	0.65	0.65
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	9.12	2.61	25.73	0.98	0.98	0.00	0.00	0.00	0.33
testis, adult, pool1	10026-101D8	37.47	25.34	24.05	4.51	2.58	1.40	4.51	0.64	3.87
testis, adult, pool2	10096-102C6	17.59	8.57	15.34	0.90	0.45	0.00	0.90	0.00	0.90
thalamus - adult, donor10196	10168-103B6	61.82	29.81	7.73	2.21	9.94	7.73	0.00	0.00	1.10
thalamus, adult, donor10252	10154-103A1	28.13	33.91	7.50	1.41	4.22	3.75	1.88	0.16	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	9.24	18.48	3.08	0.00	4.62	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	6.92	5.76	2.31	0.49	0.49	0.00	0.49	0.16	0.16
thalamus, newborn, donor10223	10366-105F6	24.16	11.51	4.03	0.00	1.73	2.30	1.15	0.00	0.00
throat, adult	10209-103G2	42.19	20.97	10.99	3.50	3.50	0.25	2.50	1.00	0.50
throat, fetal, donor1	10061-101H7	24.07	9.75	17.98	5.48	1.22	0.61	0.91	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
thymus, adult, pool1	10027-101D9	29.23	15.21	20.18	3.68	1.59	0.70	0.30	0.30	1.19
thymus, fetal, pool1	10043-101F7	48.42	37.82	31.79	4.57	3.12	2.70	1.04	0.73	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	16.89	5.32	9.17	3.46	0.80	0.13	0.00	0.13	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	25.14	8.66	8.38	3.77	1.40	0.28	0.00	0.70	0.14
thyroid, adult, pool1	10028-101E1	50.67	39.56	22.58	3.45	4.85	2.71	1.96	0.47	0.75
thyroid, fetal, donor1	10060-101H6	25.84	11.34	12.13	3.43	1.85	0.26	1.32	0.79	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	138.58	33.88	12.32	6.16	6.16	3.08	3.08	0.00	0.00
tongue, adult	10203-103F5	29.07	11.86	7.44	1.86	2.09	0.47	0.47	0.23	0.70
tongue, fetal, donor1	10059-101H5	13.40	4.73	6.31	1.18	0.79	0.39	1.58	0.39	0.00
tonsil, adult, pool1	10047-101G2	39.87	28.45	19.83	2.70	2.91	1.40	2.00	0.30	0.00
trachea, adult, pool1	10029-101E2	69.86	60.04	15.30	3.93	6.22	5.07	2.86	0.41	1.23
trachea, fetal, donor1	10058-101H4	50.39	21.93	16.93	3.08	3.08	0.77	1.92	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	12.75	3.90	4.96	2.48	0.35	0.35	0.71	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	57.45	20.97	14.59	10.13	3.04	0.10	1.11	0.61	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	167.34	17.08	20.21	14.73	5.64	0.31	1.25	2.35	1.88
tridermal teratoma cell line:HGRT	10694-109G1	17.12	1.90	3.81	0.00	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	55.19	13.80	12.44	4.83	4.74	0.25	0.51	0.25	0.34
umbilical cord, fetal, donor1	10057-101H3	27.12	4.17	8.35	2.09	2.09	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	27.30	15.02	27.81	4.10	2.22	0.51	3.92	0.85	0.34
uterus, fetal, donor1	10055-101H1	25.08	10.75	17.92	4.10	0.00	1.02	1.02	0.00	0.00
vagina, adult	10204-103F6	73.67	48.46	18.09	3.88	11.63	6.46	7.11	0.00	0.65
vein, adult	10191-103E2	46.25	28.28	21.04	2.41	3.07	2.41	3.29	0.88	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	37.39	14.95	4.27	0.80	1.87	1.60	0.27	0.00	0.00

Property "Nearest transcripts" (as page type) with input value "MP067537:10 ENST00000487389.5:114 ENST00000469266.1:124 LP895473:142 AB006746:142 AF098642:143 ENST00000486631.5:210 ENST00000448787.6:231 AK300181:231 ENST00000342435.9:244 NM_021105.3:244 AK313377:244 NM_001363874.1:256 BC017901:267 BC032718:272 ENST00000494568.5:273 ENST00000462666.5:281 ENST00000463777.5:296 ENST00000468985.5:296 NM_001363872.1:296 ENST00000477974.1:298 ENST00000489775.5:304 BC021100:310 ENST00000478267.5:313 ENST00000488253.5:321 ENST00000493432.5:330 BC070251:330" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.